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ABSTRACT OF THE DISSERTATION
ASYMMETRIC SYNTHESES OF ANALOGS OF KAINIC ACID
by
Wentian Wang
Florida International University, 2012
Miami, Florida
Professor Kathleen Rein Major Professor
Kainic acid has been used for nearly 50 years as a tool in neuroscience due to its
pronounced neuroexcitatory properties. However, the significant price increase of kainic
acid resulting from the disruption in the supply from its natural source, the alga Digenea
Simplex, as well as inefficient synthesis of kainic acid, call for the exploration of
functional mimics of kainic acid that can be synthesized in a simpler way.
Aza kainoids analog could be one of them. The unsubstituted aza analog of
kainoids has demonstrates its ability as an ionotropic glutamate receptor agonist and
showed affinity in the chloride dependent glutamate (GluCl) binding site. This opened a
question of the importance of the presence of one nitrogen or both nitrogens in the aza
kainoid analogs for binding to glutamate receptors. Therefore, two different pyrrolidine
analogs of kainic acid, trans-4-(carboxymethyl)pyrrolidine-3-carboxylic acid and trans2-carboxy-3-pyrrolidineacetic acid, were synthesized through multi-step sequences. The
lack of the affinity of both pyrrolidine analogs in GluCl binding site indicated that both
nitrogens in aza kainoid analogs are involved in hydrogen bonding with receptors,
significantly enhancing their affinity in GluCl binding site.

vi

Another potential functional mimic of kainic acid is isoxazolidine analogs of
kainoids whose skeleton can be constituted directly via a 1, 3 dipolar cycloaddition as the
key step. The difficulty in synthesizing N-unsubstituted isoxazolidines when applying
such common protecting groups as alkyl, phenyl and benzyl groups, and the requirement
of a desired enantioselectivity due to the three chiral ceneters in kainic acid, pose great
challenges. Hence, several different protected nitrones were studied to establish that
diphenylmethine nitrone may be a good candidate as the dipole in that the generated
isoxazolidines can be deprotected in mild conditions with high yields. Our investigations
also indicated that the exo/endo selectivity of the 1, 3 dipolar cycloaddition can be
controlled by Lewis acids, and that the application of a directing group in dipolarophiles
can accomplish a satisfied enantioselectivity. Those results demonstrated the synthesis of
isoxazoldines analogs of kainic acid is very promising.
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1. Introduction
1.1 Neurotransmitter receptors
Neurotransmitter receptors function as integral components that allow communication
between adjacent cells of the nervous system. They span the width of the postsynaptic
membrane and protrude into the synaptic cleft and into the cell cytoplasm. The effects of
neurotransmitters are mediated through a noncovalent, reversible interaction, causing a
conformational change in the receptor protein. Consequently, this change results in either
an alteration in the permeability of certain ions through the membrane (transduction
mechanism 1) or the activation of intracellular enzymes (transduction mechanism 2). Ion
channel receptors are multisubunit proteins and mediate rapid synaptic transmission. The
majority of neurotransmitter receptors that activate intracellular enzymes are
metabotropic or G protein-coupled receptors and are single-subunit proteins that mediate
slower responses at the synapse [Stephenson, F. A. and Hawkins, L. M. 2001].

Activation of the neurotransmitter receptors is a result of noncovalent and reversible
interaction with neurotransmitters. To be considered a neurotransmitter, a compound
must meet four criteria: (1) it is presynaptically localized in specific neurons and released
from synaptic vesicles; (2) it is released by physiological stimuli in concentrations high
enough to generate postsynaptic responses; (3) there are mechanisms that will rapidly
terminate its action; and (4) it exhibits pharmacological identity with the transmitter,
including response to antagonists [Cooper, J. R. et al.1992][Fonnum, F. 1984].
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The early concept that each neurotransmitter only activates a single type of receptor was
revolutionized with the advent of molecular cloning. It is currently believed that a family
of neurotransmitter receptors exists for each neurotransmitter. More than 50
neurotransmitters have been discovered, and each one binds to its own family of
neurotransmitter receptors [Stephenson, F. A. and Hawkins, L. M. 2001].
Neurotransmitters fall into three main categories: amino acids (mostly glutamic acid
(Glu) 1, γ-amino butyric acid 2, aspartic acid 3 and glycine 4), peptides (e.g., vasopressin,
somatostatin, neurotensin), and amines (norepinephrine 5, dopamine 6, serotonin 7 and
acetylcholine 8) [Rousseaux. C. G. 2008]. The specificity of selectivity makes the
neurotransmitter receptors a primary target for pharmacological intervention. Drugs that
can trigger responses by binding to the same receptors as neurotransmitters are receptor
agonists, whereas receptor antagonists are drugs that block or dampen agonist-mediated
responses and do not provoke any biological response upon binding to the same site on
the neurotransmitter receptor [Stephenson, F. A. and Hawkins, L. M. 2001] [Cooper, J.R.
et al. 1992].
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1.2 Glutamic acid and its receptors
L-glutamic

acid (Glu), one of 20 proteinogenic amino acids, possesses numerous

functions as listed in Table 1 [Rousseaus, C. G. 2008].
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Table 1. Biological functions of glutamate
1

Substrate for protein synthesis

2

Precursor of glutamine

3

N transport (muscle-glutamine; brain)

4

Neurotransmitter (and γ-aminobutyrate)

5

Polyglutamate and cell signaling

6

D-Carboxylation

7

Substrate for glutathione production

8

Precursor of N-acetylglutamate

9

Active sites of enzymes

of glutamate

10 Inhibitor of glutaminase reaction
11 Citric acid cycle intermediate
12 Energy source for some tissues (mucosa)

Glu and its metabolism and function in the detoxification of ammonia in the brain, as
well as its role as a building block in the synthesis of proteins and peptides, have been
studied for decades. However, the notion that Glu functions as a neurotransmitter was
controversial when first proposed in the early 1950s [Hayashi, T. 1956][Curtis, D. R. and
Watkins, J. C. 1960][Cotman, C. W. and Iversen, L. L. 1987][Fonnum, F. 1984]. Starting
in the early 1980s, strong evidence accumulated from several studies to support the role
of glutamic acid as an excitatory neurotransmitter in the mammalian central nervous
system (CNS) [Fonnum, F. 1984]. Glu is synthesized, stored, and released from the
presynaptic terminal. It binds to specific neurotransmitter receptors localized on the
postsynaptic cells and is then removed from the synaptic cleft. Therefore, it fulfills the
four requirements of a neurotransmitter. Through both ligand-gated ion channels at
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ionotropic receptors (iGluRs) and at G protein-coupled metabotropic receptors (mGluRs),
L-Glu

activates its corresponding receptors, contributing to basal excitatory synaptic

transmission. Therefore, it is an excitatory neurotransmitter [Rousseaus, C. G. 2008].

In the mammalian CNS, Glu and aspartate (Asp) act as major excitatory
neurotransmitters to stimulate or excite postsynaptic neurons. Glu is estimated to mediate
approximately 50% of all synaptic transmissions in the CNS and is involved in almost all
aspects of normal brain function including learning, memory, movement, cognition, and
development [Rousseaus, C. G. 2008].

However, Glu, Asp, and structurally similar compounds, such as domoic acid 9, can be
neurotoxic when they excessively stimulate the same excitatory receptors, and this action
is postulated to be involved in the pathogenesis of some types of acute and chronic insults
to the CNS [Rousseaus, C. G. 2008][Choi, D. W. 1995]. This excitotoxic effect can be
significant during acute diseases such as ischemic stroke and trauma, or moderate but
prolonged in such chronic neurodegenerative diseases as Alzheimer’s disease,
Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis [Beal, M. F.
1995][Starr, M. S. 1995][Plaitakis, A. et al. 1996][Shaw, P. J. and Ince, P. G. 1997].
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Early studies classified glutamate receptors as either N-methyl-D-aspartate (NMDA) 10
receptors or non-NMDA receptors based on the NMDA-selective activation of these
receptors. In the early 1980s, under conditions in which a prolonged excitatory
postsynaptic potential was observed in response to intense stimulation of presynaptic
fibers, NMDA receptors were demonstrated to be involved in several central synaptic
pathways, acting together with non-NMDA receptors. Such activation results in the
phenomenon of long-term potentiation, which is associated with lasting changes in
synaptic efficacy (synaptic plasticity) and is considered an important process in memory
and learning [Rousseaux. C. G. 2008] [Bliss, T. V. P. and Collingridge, G. L.
1993][Chapman. P. F. et al. 1990]. Almost simultaneously, a new class of glutamate
receptors in the brain that are distinct from NMDA and non-NMDA receptors were
discovered that mediate biochemical changes. This dichotomy was later addressed in the
early 1990s with the identification of a second family of glutamate receptors, the mGluRs
[Rousseaux. C. G. 2008]. Later, non-NMDA receptors were further divided into α-amino3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) 11 and kainate (KA) 12
receptors in terms of the agonist’s preferential activation of these receptors. Presently, as
shown in Figure 1, glutamate receptors are broadly characterized into two classes: the
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mGluRs and iGluRs. Both mGluRs and iGluRs participate in a range of central synaptic
processes, including synaptic plasticity. The former are coupled to intracellular signal
transduction through G proteins and mediate slow excitatory responses. By contrast, the
latter are responsible for fast excitatory responses by functioning as ion channels [Bunch,
L. and Larsen, P. K. 2009][Lujan, R. et al. 1996]. iGluRs are cation channels and are
further classified into three subtypes: NMDA, AMPA, and KA receptors. However, not
all iGluRs are exclusively cation channels. A small family of iGluRs with glutamategated chloride channels has been discovered, although these receptors are not well
studied and are still under investigation [Brockie, P. J. and Maricq, A. V. 2006]. The
classification of glutamate receptors is shown in Figure 1.

Glutamate

Excitatory amino acid receptors

Metabotropic receptors

Iontropic receptors

NMDA

AMPA
Cations

Kainate

Cl- dependent
Anion

Figure 1. Classification of glutamate receptors

7

Because iGluRs with anion channels account for a very small portion of iGluRs, the term
“iGluRs” refers only to ionotropic glutamate receptors with cation channels, unless
otherwise specified.

iGluRs are ligand-gated ion channels and mediate the vast majority of excitatory
neurotransmission in the brain. iGluRs have different physiological and pharmacological
properties and are differentially localized throughout the CNS, where they form
heteromeric subunit assemblies and are composed of different subunits [Rousseaux. C. G.
2008]. Most iGluRs incorporate ion channels that allow cations to permeate. However,
the membrane channels associated with these receptors exhibit different selectivity to
sodium (Na+), potassium (K+), and calcium (Ca++). The non-NMDA receptors, including
AMPA and KA receptors, control a nonselective cationic channel permeable to the
monovalent cations K+ and Na+, whereas NMDA gates an ion channel that is more
permeable to Ca++ ions than the AMPA or KA receptors [Rousseaux. C. G.
2008][Meldrum, B. S. 2000].

Several gene families encoding iGluRs have been identified by recombinant DNA
technology. The AMPA family consists of iGluR 1-4 (iGluRA-D); the KA family is
composed of iGluR 5-7 and KA 1-2; and the NMDA family includes NMDAR 1,
NMDAR 2A-D, and NMDAR 3 (Figure 2).

8

Ionotropic glutamate receptors
(cation channels)

NMDAR
1

NMDAR
2A-D

Kainate

AMPA

NMDA

NMDAR
3A

GluR 1-4

GluR
5-7

KA
1-2

Figure 2. Families of ionotropic glutamate receptors

Learning and memory rely on persistent changes in synaptic plasticity that require
neuronal gene expression. AMPA and NMDA GluRs play different roles in controlling
synaptic plasticity. AMPA receptors influence short-term changes in synaptic plasticity,
whereas NMDA receptors mediate gene expression that participates in the long-term
maintenance of these changes [Rao, V. R. and Finkbeiner, S. 2007].

The subunits that assemble to form iGluRs may or may not be homologous, and different
combinations of subunits are found. However, through gene transcription, different
regions of the resultant mRNA molecule can be spliced together, leading to multiple
mRNAs that are translated into different proteins. This phenomenon is known as splice
variation, a very common finding among neuroreceptors. The C-terminus of iGluRs is the
site of extensive splice variation, leading to different important functions, because the C-
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terminus is also the site of multiple protein-protein interactions. RNA editing is a further
modification leading to diversification, and some nucleotides in the mRNA sequence
transcribed from the gene sequence are selected and enzymatically modified, changing
the amino acid coded by the mRNA sequence. RNA editing can lead to fundamental
consequences for the Ca++ permeability of subunits, e.g., the AMPA-type subunit GluR2
and the KA receptor subunit GluR5 [Clarke V. R. J. et al. 1997][Rousseaux. C. G. 2008].

Diverse NMDA receptors [Katsuwada, T. et al. 1992], which are perhaps the best
characterized of the iGluRs, are composed of assemblies of NMDAR 1 subunits and one
or more NMDAR 2A-D subunits. The Glu-binding domain of the receptor is present at
the junction of the NMDAR 1 and NMDAR 2 subunits. Hence, expression of both
subunits is necessary to form functional channels. Among those subunits, NMDAR 1 is
more highly distributed in the cortex, caudate, and hippocampus and forms the channel;
other subunits (NMDAR 2A-D) are involved in receptor modulation. NMDAR 1 is
linked to a Na+ and Ca++ ion channel that has five different binding sites, including two
distinct agonist recognition sites, one for Glu and the other for Glycine (Gly). The
NMDA receptor requires both Glu and a co-agonist, Gly, to bind for receptor function.
Of the NMDAR 2 groups, NMDAR 2A is expressed ubiquitously with the greatest
densities in hippocampal regions. The NMDAR 2B subunit has a binding site for
polyamines, regulatory molecules that mediate the function of the NMDA receptor
[Chenard B. L. and Menniti, F. S. 1999][Rousseaux. C. G. 2008]. NMDAR 2C and
NMDAR 2D may form heteroligomeric receptors with both NMDAR 1 and NMDAR
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2A, providing a basis for the development of drugs selectively aimed at spinal cord
disorders [Sundstrom E. et al. 1997].

NMDA receptors are inactive at resting membrane potentials because of a voltagedependent block of ion flow through the channel pore by Mg++ ions. Sustained activation
of AMPA receptors depolarizes the postsynaptic cell, releasing the channel inhibition and
allowing NMDA receptor activation [Rousseaux. C. G. 2008]. NMDA receptor activation
results in Ca++ influx into the postsynaptic cells. Thus, NMDA receptors are highly
permanent for Ca++ ions. They demonstrate slower gating kinetics when the channel is
blocked in a voltage- and use-dependent manner by physiological concentrations of Mg++
ions [Nowak, L. et al. 1984]. These properties provide NMDA receptors with their role as
a coincidence detector underlying synaptic plasticity in learning, chronic pain, drug
tolerance, and dependence [Rousseaux. C. G. 2008].

AMPA receptors, localized in the hippocampus and striatum, play an important role in
mediating most forms of fast glutamatergic neurotransmission in response to a Ca++
influx [Chavez, A. E. et al. 2006]. AMPA receptors have four known subunits, GluR1 to
GluR4, which are widely but differentially distributed throughout the CNS [Hollmann,
M. and Heinemann, S. 1994]. The types of subunits forming a receptor usually determine
the receptor’s biophysical properties and pharmacological sensitivity [Rousseaux. C. G.
2008].
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“Flip” and “flop,” two alternative splice variants of GluR1 to GluR4 subunits, exhibit
varying levels of expression throughout the brain and during development and impart
distinct pharmacological properties [Partin K. M. et al. 1996][Parsons C. G. et al. 1993].
The GluR2 subunit controls the permeability of Ca++ into AMPA receptor channels.
Posttranscriptional editing of GluR2 mRNA, which changes a single amino acid in the
transmembrane II (TMII) region from glutamine (Q) to arginine (R), determines the Ca++
permeability of the GluR2 subunit. This phenomenon is called the Q/R editing site. When
it is in the GluR2(Q) form, it is Ca++ permeable, whereas GluR2(R) is not. Almost all
GluR2 protein expressed in the CNS is in the GluR2(R) form, leading to Ca++impermeable native AMPA receptors. Based on this and the interactions with other
intracellular proteins, GluR2 has been described by some as the most important AMPA
receptor subunit [Rousseaux. C. G. 2008].

Like AMPA, KA receptors are also localized in the hippocampus and striatum. They
may play a role in the generation of seizures if overstimulated [Vignes M. et al. 1997].
Multimeric assemblies of GluR5-7 and KA-1-/2 subunits form KA receptors. KA
receptors have an extracellular N-terminus that produces the ligand-binding domain and a
re-entrant loop (TMII), combined with a loop between TMIII and TMIV, to form the
lining of the pore region in the ion channel. Both splice variation and RNA editing also
provide the KA receptor family with numerous possible receptors with different
pharmacological and functional properties [Chittajallu, R. et al. 1999]. KA receptors can
not only act as presynaptic autoreceptors to facilitate synaptic transmission [Contractor
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A. et al. 2001], but are also involved postsynaptically in neurotransmission in some
pathways [Rousseaux. C. G. 2008].

In addition to cation-permeable iGluRs, there is a small family of glutamate-gated
chloride channels (GluCl) that has been identified in Caenorhabditis elegans [Brockie, P.
J. and Maricq, A. V. 2006]. Based on the investigation of Cully and associates [Cully, D.
F. et al. 1994], those channels are permeant to chloride ions and are sensitive to
avermectin, an anthelmintic drug. Thus far, the GluCl channels seem to be specific to
invertebrates. Six genes that encode GluCl subunits in C. elegans have been discovered:
glc-1, glc-2, glc-3, glc-4, avr-14/gbr-2, and avr-15 [Cully, D. F. et al. 1994][Dent, J. A.;
1997][Vassilatis, D. K. et al. 1997][Laughton, D. L. 1997][Dent, J. A. et al.
2000]Horoszok, L. et al. 2001]. GluCls function in pharyngeal pumping, sensory
perception, and locomotion [Brockie, P. J. and Maricq, A. V. 2006].

mGluRs were discovered and established as a new type of excitatory amino acid receptor,
with a family of eight single-polypeptide chain receptors that function via coupling to G
proteins. mGluRs are classified into four groups (Group I-IV) according to amino acid
sequence similarities, agonist pharmacology, and the signal transduction pathways to
which the mGluRs are coupled [Narahashi, T. et al. 1992]. The co-assembly of several
subunits forms each different group of receptor. All eight subunits (mGluRs 1-8) have
been cloned [Rousseaux. C. G. 2008]. mGluRs 1, 5, and 6 form Group I, which
stimulates inositol phosphate metabolism and mobilization of intracellular Ca++. Both
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Group II (mGluRs 2 and 3) and Group III (mGluRs 4, 6-8) are coupled to adenyl cyclase,
whereas Group IV is coupled to the activation of phospholipase D (Figure 3) [Rousseaux.
C. G. 2008]. However, Group IV is activated more efficiently by L-cysteinesulfonic acid
than Glu, suggesting that L-cysteinesulfonic acid probably functions as an endogenous
agonist of this receptor [Conn, P. J. and Pin, J. P. 1997].

Metabotropic glutamate
receptors

Group I

mGluR
1

mGluR
5

Group III

Group II

mGluR
2

mGluR
3

mGluR
4

mGluR
6

Group IV

mGluR
7

mGluR
8

Figure 3. Classification of mGluRs
mGluRs are similar to iGluRs in that they both bind Glu and Glu binding can affect the
permeability of ion channels. However, mGluRs have certain features that are different
from iGluRs. First, mGluRs modulate the activity of neurons instead of mediating fast
synaptic

neurotransmission.

Second,

mGluRs

are

localized

differently

and

heterogeneously. Different subclasses are uniquely distributed at both the anatomical and
cellular levels; for example, mGluRs 2 and 3 are more concentrated in the cerebral
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cortex, whereas mGluR 4 is expressed at high density in the thalamus and mGluR 6 is
exclusively found in the retina [Rousseaux. C. G. 2008].

Activation of mGluRs changes local transmitter release and behaviors of experimental
animals. In particular, mGluRs mediate phosphorylation of several key signaling
proteins, such as protein kinases and transcription factors, leading to significant changes
in immediate early gene and neuropeptide gene expression in striatal neurons. mGluRs
are considered to play a pivotal role in the development of synaptic and neuronal
plasticity underlying long-term adaptive changes in cellular physiology, which is related
to various neurological disorders [Rousseaux. C. G. 2008]. mGluRs also mediate
dopamine transmission, which is substantially involved in many neurological disorders
[Hu, G. et al. 1999].

1.3 Kainic acid and its synthesis
Kainic acid 12 is the parent of a class of non-proteinogenic amino acids known as the
kainoids 13.

HO2C

4

R

3

5

HO2C 2 N
H 1
Kainoids
13

For the past 50 years, the neuroexcitatory properties of kainoid amino acids have
provoked numerous investigations. Kainoid amino acids have a structure similar to
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glutamic acid, a mammalian CNS neurotransmitter [Parsons, A. F. 2005]. The kainoid
amino acids are a special group of non-proteinogenic pyrrolidine dicarboxylic acids.
They have a general structure 13 with three asymmetric centers at positions 2, 3, and 4 of
the pyrrolidine ring. The substituent at the C-4 position of the ring, generally containing
π-unsaturation, can vary, giving rise to various members of the kainoid family [Parsons,
A. F. 1996]. For instance, when the substituent at C-4 is an octadienoic side chain, the
kainoid is domoic acid 9, which was originally isolated from a Japanese marine algae, the
warm water algae Chondria armata [Takemoto, T. and Daigo, K. 1958]. The acromelic
acids A 14 and B 15 are kainoids with a functional 2-pyridone substituent at C-4. They
were first isolated from the mushroom Clitocybe acromelalga [Konno, K. et al. 1983].
Both (−)-kainic acid and (+)-allokainic acid 16 bear an isopropenyl group at the C-4
position but with opposite configurations. Kainic acid and its C-4 epimer, allokainic acid,
were first isolated from a Japanese marine algae Digenea simplex in 1953 [Murakami, S.
et al. 1953].

CO2H

HO2C

NH

HO2C
HN

O

Acromelic acid A
14

O

HO2C

NH

HO2C
HN

CO2H

Acromelic acid B
15

HO2C
HO2C

N
H

(+)-allokainic acid
16

Kainoids have been extensively investigated for their pronounced neuroexcitatory
properties. The kainoids selectively block neuronal processes and are consequently
valuable tools in the study of neurofunctioning. Their excitotoxicity in both the vertebrate
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and invertebrate glutamergic system causes specific neuronal death in the brain [Parsons,
A. F. 1996]. Researchers have discovered that after injection of kainoids, the
pharmacological effects and patterns of neuronal degeneration are very similar to the
symptoms observed in patients who suffer from neurological diseases such as epilepsy
and Huntington’s disease [Sperk, G. 1994][Coyle, J. T. and Schwarcz, R. 1976][Mcgeer,
E. G. and Mcgeer, P. L. 1976].

Numerous structure-activity investigations of the naturally occurring and synthetic
kainoids have established that the C-4 stereochemistry, the nature of the C-4 substituent,
and its conformation play an essential role in binding and functional activation at the
recognition site. i.e., kainic acid is more neuroexcitatory than its C-4 epimer, and
allokainic has the opposite configuration at the C-4 position [Hansen, J. J. and
Kroqsqaard-larsen, P. 1990]. An investigation by Ishida, M. et al.. [Ishida, M. and
Shinozaki, H. 1991] indicated that an unsaturated substituent at C-4 is significantly
related to the excitatory activity. Hashimoto, K. et al. synthesized and studied a series of
conformationally constrained analogs 17-20 of kainic acid and found that all those
compounds showed very weak activities in newborn rat spinal motoneurons compared
with kainic acid [Hashimoto, K. et al.1995].
CO2H

CO2H
H

H
N
H
17

H

H

CO2H

N
H
18

17

CO2H

CO2H

CO2H

H

H
N
H

H

H

CO2H

N
H
20

19

CO2H

In addition to the pronounced neuroexcitatory properties, kainoids also draw considerable
research interest due to their insecticidal and anthelmintic activities. Inhabitants of
Yakushima Island in Japan have long used an extract of red algae, from which kainic acid
and domoic acid are isolated, to kill flies [Parsons, A. F. 1996]. In addition, Meda, M. et
al.. found that subcutaneous injection of domoic acid and the isodomoic acids A-C 21-23
into the abdomen of the American cockroach (Periplaneta americana) can lead to this
insect’s death [Meda, M. et al. 1986], demonstrating their potent insecticidal properties.
However, research has also revealed that the insecticidal properties greatly rely on the
nature of the side chain at the C-4 position of the pyrrolidine ring. Therefore, the potency
of domoic acid in killing the American cockroach is 23 times that of isodomoic acid C
[Parsons, A. F. 1996].

COOH

HOOC

N
H

COOH

HOOC

COOH

N
H

Isodomic acid A (Z, E) 21
Isodomic acid B (E, E) 22

COOH

Isodomic acid C 23

For over 1000 years, the Japanese have taken advantage of the anthelmintic (antiintestinal worm) activities of Digenea simplex, the algae from which kainic acid was first
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isolated [Parsons, A. F. 1996]. The active component, kainic acid, was extensively
investigated and found to have powerful anthelmintic activity without side effects
[Watase, H. et al. 1958]. Interestingly, the cis relative configuration between C-3 and C-4
is also essential to the anthelmintic function. This is why kainic acid has a much stronger
anthelmintic effect than its C-4 epimer, allokainic acid [Parsons, A. F. 1996].

Due to these crucial biological properties of kainoids, they not only arouse numerous
functional investigations but also attract enormous attention for synthesizing these
compounds. However, synthesis of kainoid amino acids is a considerable challenge. Any
synthesis must address the formation of a pyrrolidine-2-carboxylic acid with defined
stereochemistry at the three continuous chiral centers of the pyrrolidine ring. Usually, the
cis relative configuration between C-3 and C-4 is preferred. The other consideration for
ideal synthesis of kainoids is having the option to easily introduce different side chains at
C-4 to produce various known kainoids and their analogs [Parsons, A. F. 1996].

Among kainoid amino acids, kainic acid, the prototypical kainoid, has attracted the most
interest in syntheses. A number of syntheses have been explored. As of 2012, 66
syntheses of kainic acid are present in the Chemical Abstracts CAS file. Early syntheses
were relatively inefficient and nonstereoselective [Parsons, A. F. 1996]. Later, a variety
of stereoselective syntheses were developed with the common feature that the
stereocontrolled formation of the C-3 to C-4 bond is achieved under the steric effect of
the C-2 substituent via cyclization, Claisen rearrangement reaction, Pauson-Khand
reaction, tandem Michael addition, etc. [Parsons, A. F. 1996].
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In 1982, a stereocontrolled intramolecular ene reaction (Scheme 1) reported by Oppolzer
and Thirring [Oppolzer, W. and Thirring, K. 1982] stands as the first enantioselective
synthesis of kainic acid. The key step, the ene cyclization reaction, was conducted with
75% yield, and the overall yield of the 10-step sequence was 4.8%. Their work also
resulted in the establishment of absolute configuration of (−)-kainic acid.
CO2Et
TBDMSO

N
Boc

EtO2C

Toluene, 130 oC, 40 h
75%

N
Boc

THBDMSO

Scheme 1. Intramolecular ene cyclization
Hanessian, S. and Ninkovic, S. [Hanessian, S. and Ninkovic, S. 1996] employed a
diastereoselective radical cyclization to generate a pyrrolidine intermediate that was
converted into (−)-kainic acid after eight additional steps. This cyclization resulted in an
excellent 88% yield with a 2.8:1 cis/trans selectivity (Scheme 2).

CO2tBu

N
O

O

Me3SnCl
NaCNBH3

t-BuOH, reflux, AIBN
88%

Me3Sn

Me3Sn

N
O

CO2tBu

+

N
O

O
2.8

:

CO2tBu

O

1

Scheme 2. Diastereoselective radical cyclization

Baldwin and co-workers [Baldwin, J. E. and Li, C-S. 1987] used a cobalt-mediated
cyclization reaction to prepare kainic acid (Scheme 3). In the presence of cobaloxime (I),
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the cyclization gave rise to a separable 5:3 syn- to anti-pyrrolidine mixture in an 80%
total yield.

I

OBn

N
CO2Ph

Cobaloxime (I)

OTBDMS

OBn

OBn

OTBDMS +

OTBDMS

N
CO2Ph

N
CO2Ph

50%

30%

Scheme 3. Cobalt-mediated cyclization

Cooper and co-workers used a stereocontrolled enolate Claisen rearrangement (Scheme
4) to obtain the desired relative stereochemistry at the 3, 4-position. A deprotonation step
by Lithium diisopropylamide in the presence of a silyl trapping agent formed an enolate,
which produced the Claisen rearrangement via a boat-like transition state to produce the
pyrrolidine [Cooper, J. et al. 1987].

O

TIPSO

O
LDA, TBDMSCl
THF, -100oC
N
CO2Et

O

i. -100oC to r.t. TIPSO
ii. K2CO3, r.t., 2h

H

TBDMSO

NCO2Et

EtO2C

CO2H
N

OTIPS

Scheme 4. Stereocontrolled enolate Claisen rearrangement

The Pauson-Khand reaction (Scheme 5) was used by Yoo, S-E and Lee, S. H. in the
synthesis of (−)-kainic acid. An oxazolidinone ene-yne reacted with dicobalt
octacarbonyl, followed by trimethylamine N-oxide, to form an enone, a desired kainic
acid precursor in 93% yield [Yoo, S-E. and Lee, S. H. 1994].
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O
i. Co2(CO)8
ii. Me3NO

N
O

N
O

O

O
93%

Scheme 5. Pauson-Khand reaction to prepare a kainic acid precursor

A tandem Michael addition reaction (Scheme 6) was developed by Benetti and coworkers as the key step to prepare (−)-kainic acid. A secondary amine reacted with 2methyl-3-nitrobuta-1,3-diene formed in situ from 3-methyl-2-nitrobut-3-enyl benzoate to
yield the desired pyrrolidine in 88% yield. Later, for the synthesis of (−)-kainic acid, the
nitro group was removed through a hydride transfer reaction, with retention of
configuration, in the presence of a palladium catalyst [Barco, A. et al. 1992].

PhOCO
CO2Et

NHBn

in situ
CO2Et

O2 N

O2N

EtO2C
NO2

NO2

EtOH, 15h, r.t.

OH

OH

N
Bn

HO

N
Bn
88%

Scheme 6. Tandem Michael addition

All examples used a stereoselective ring closure under the steric effect of the C-2
substituent to constitute the highly functionalized pyrrolidine ring of kainic acid.
Although these methods successfully realized the three contiguous asymmetric centers of
(−)-kainic acid, their yields were not satisfactory [Parsons, P. 2011].
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Kainic acid has been used for nearly 50 years as a tool in neuroscience due to its
pronounced neuroexcitatory properties. For decades, kainic acid was commercially
available from its most abundant natural source, the alga Digenea simplex [Murakami, S.
et al. 1953]. In 1999, however, a disruption in the supply of kainic acid [Tremblay, J.-F.
2000] resulted in a significant price increase, making development of an efficient
synthetic route for kainic acid more desirable. Unfortunately, the challenges in kainic
acid synthesis prohibit large-scale preparation, even though numerous total syntheses and
synthetic approaches have been reported. This greatly limits kainic acid’s application in
research.
1.4 Objective of research
To address this problem, analogs of kainic acid that exhibit the same biological activity
as kainic acid but are easier to prepare are of considerable interest. Aza kainoid analogs
24 could be one type of analog.
R
HN

CO2H
CO2H

N
H
24

Molecular modeling/docking studies fitting the aza analog of KA into the binding site of
the iGluR6 suggest that the aza-kainoid analogs can fit well and fully reproduce all
critical ligand receptor interactions [Di, M. 2006].

A simple unsubstituted aza kainoid 25 was prepared in racemic form (Scheme 7). During
an Hg/Al reduction step, the all-trans adduct was converted to a mixture of cis and trans.
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However, the two diastereomers were separable, which allowed for testing of the trans
pyrazolidine after hydrogenolysis of the benzyl protecting groups [Simovic, D. 2008].

OBn

BnO
O

CH2N2

O

CO2Bn
N

N

CO2Bn

_
(+)

CO2Bn

Hg/ Al

95%
two steps

HN

N
H

CO2Bn

+
HN
N CO2Bn
CO2Bn
H
_
_
(+)
(+)

Scheme 7. Reduction of 1-pyrazoline prior to isomerization

Preliminary activity studies using Aplysia californicus indicated that application of this
unsubstituted aza-kainoid 25 induced an inward current in Aplysia neuronal cells,
demonstrating the ability of aza kainoids to function as iGluR agonists [Simovic, D.
2008].
HO2C
HN

CO2H
1
HN
2N
H
26

CO2H

N
H
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CO2H

The affinity of compound 25 was tested in AMPA-, KA-, NMDA-, and chloridedependant glutamate binding sites (Figure 4). The affinity of 25 for the chloridedependent glutamate binding site was clear [Simovic, D. 2008].
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Figure 4. The affinity of compound 25 at AMPA- (■), Kainate- (▼), NMDA- (♦), and
chloride-dependent (▲) glutamate binding sites.
In the crystal structures of iGluRs bound to kainic acid, the NH of kainic acid hydrogen
bonds with the side chain of a Glu residue and a proline carbonyl [Bunch, L. and
Krogsgaard-Larsen, P. 2009]. Molecular modeling/docking studies using the program
Macromodel

docking

show

(3S,4S,5S)-4-(carboxymethyl)-5-(prop-1-en-2-

yl)pyrazolidine-3-carboxylic acid 26 in the ionotropic glutamate receptor binding site of
iGluR6 (Figure 5), suggesting that the nitrogen at position 1 of this aza analog may
reproduce some the critical interactions between the kainic acid -NH and the receptor [Di,
M. 2006]. This led us to ask if both nitrogens or a single nitrogen in compound 25 are
required for binding.

25

Figure 5. Compound 26 inserted into the iGluR6 crystal structure and minimized with
Macromodel using the AMBER force field. Purple lines are hydrogen bonds within the
receptor. Green lines are hydrogen bonds between the receptor and ligand.
Therefore, our first objective was to identify the amine group(s) involved in hydrogen
bonding with iGluR in compound 25. We proposed the synthesis of trans-4(carboxymethyl)pyrrolidine-3-carboxylic acid 27. To our surprise, this compound has
never been synthesized or tested as a glutamate antagonist. A single citation appears in
the literature for this compound [Miyamoto, M. et al. 1957]. The abstract of this paper
describes this as an active component isolated from Diginea simplex, the same seaweed
that produces kainic acid. If 27 can activate iGluR, not only will the -NH at position 5 of
compound 25 be confirmed to be the one bonding with iGluR, but this result will also
open the opportunity to explore another new class of kainoid analog, isoxazolidines,
which may also be prepared by a dipolar cycloaddition. The rationale behind this
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assumption is that isoxazolidines bear a nitrogen located at the same position in the fivemembered ring as compound 27 does. Thus, it is highly possible for isoxazolidine
kainoid analogs to possess the ability to activate iGluR. As such, compound 28 was
designed to test its ability to activate iGluR.

Ph 3

CO2H

HN

CO2H
4

HN O 5

CO2H
27

CO2H

28

The objectives of this proposal are summarized briefly below
1.

Synthesize compound 27 in order to determine if the location of the nitrogen is
critical to binding and activity of kainoids at iGluR receptors.

2.

Explore the synthesis of isoxazolidine 28 via 1, 3-dipolar cycloaditions using
nitrones as the dipole.

3.

Evaluate affinity of kainic acid analogs for glutamate receptors by competitive
assays against [3H] kainic acid.

1.5 Experimental Design

I.

Synthesis of trans-4-(carboxymethyl)pyrrolidine-3-carboxylic acid 27

Scheme 8 illustrates the planned synthesis of 27. Reductive alkylation of benzyl-βalanine with benzaldehyde will produce N-benzyl benzyl-β-alanine. After alkylation of
the amine with benzylbromocrotonate, an intramolecular Michael addition will provide a

27

pyrrolidine intermediate. We anticipate the more stable trans product will be more
abundant. However, we also expect the cis/trans diastereomers to be readily separable.
Hydrogenolysis of the benzyl prtotecting group will yield 27.

H2N

Br

CO2Bn

PhCHO

CO2Bn
BnN

Ph

N

CO2Bn NaBH4

CO2Bn KHMDS

BnN

BnHN

CO2Bn Hydrogenolysis
CO2Bn

CO2Bn

CO2Bn

27

Scheme 8. Synthetic design of targeted compound 27

II. Synthesis of isoxazolidine analog of kainoids 28
Kainoid analog 28 will be prepared by 1, 3 dipolar cycloaddition. It is a very powerful
synthetic reaction for the construction of variously functionalized five-membered
heterocycles [Pellissier, H. 2007] with control over relative stereochemistry. This reaction
involves 2 π-electrons of the dipolarophile and 4 π-electrons of the dipole which take part
in a concerted, pericyclic shift. This reaction is a [2s+4s] suprafacial cycloaddtion, so it is
stereoconservative and the relative configuration of the dipolarophile will be retained
[Carey, F. A. and Sundberg, R. J. 1991]. The relative orbital energies of both the
dipolarophile and the dipole HOMOs and LUMOs govern regioselectivity. Generally,
electron-withdrawing groups on the dipolarophile favor an interaction of the LUMO of
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the dipolarophile with the HOMO of the dipole while electron donating groups on the
dipolarophile normally favor the inverse of this interaction [Houk, K. N. 1972].

Therefore, when acting as a dipolarophile, an α, β-unsaturated ester will favor the
interaction of the LUMO of the dipolarophile with the HOMO of the dipole, resulting in
the regioselectivity such that the terminal heteroatom of the dipole will attack the αcarbon of the ester [Carey, F. A.; Sundberg, R. J. 1991][Houk, K. N. 1972]. For instance,
in the 1, 3 dipolar cycloaddition of nitrones with α, β-unsaturated esters, the oxygen atom
of nitrones will form a new bond with the α-carbon of the esters(Figure 6).
CO2R4

R4O2C

O

R2

N

R3

R3

N O

R1
R1

R2

CO2R4
CO2R4

Figure 6. Interaction of the LUMO of α, β-unsaturated esters with the HOMO of nitrones
Isoxazolidine analog of kainoids 28 will be prepared via 1, 3 dipolar cycloaddition from a
specific nitrone. The benzyl protecting group of the nitrone is used for optimizing the
cycloaddtion (scheme 9), but we are aware of the need to develop an alternative
protection/deprotection strategy.

N-benzylidene-benzylamine N-oxide is synthesized according to the method described by
Sharma, V. B et al. [Sharma, V. B. et al. 2003]. The immediate product of the
cycloaddition is an isoxazolidine which will not require reduction. This will avoid the
isomerization issue of the 1, 3 dipolar cycloaddition between diazoalkanes and
unsaturated esters, thus preventing the loss of one chiral center.
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In scheme 9, because of the π-interaction in the transition state [Huisgen, R. and
Eberhard, P. 1971], the 4, 5-cis-relative configurations in kainoid analog 28 after the 1,3
dipolar cycloaddition will be expected to predominate. In order to control the absolute
configuration, chiral catalysts may be used. Kanemasa, S. et al. [Kanemasa, S. and Kanai.
T. 2000] and Gothelf, K. V. et al. [Gothelf, K. V. et al. 1994] have applied some chiral
catalysts to 1, 3 dipolar cycloaddition reactions of nitrones.

CO2Bn
Ph
-

O

H
N+

+
Bn

Dipolar
Cycloaddition

Ph
N O
Bn

BnO2C

CO2Bn
Deprotection
CO2Bn

28

Hydrolysis

Scheme 9. Synthetic design of isoxa analog 28
II.

Evaluation of 27 and 28 for kainite receptor affinity

The binding affinity of compounds 27 and 28 will be evaluated in a competitive
displacement assay against [3H] kainic acid. This test will be done by a commercial
vendor (Caliper).
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2. Synthesis of pyrrolidine analogs of kainic acid
2.1 Synthesis of trans-4-(carboxymethyl)pyrrolidine-3-carboxylic acid
2.1.1 Experimental results and discussion
In our original synthetic plan (Scheme 8), two intermediates 29 and 30 were designed to
be prepared with an intention of removing all benzyl groups by hydrogenolysis after
Michael addition. The preparation of 29 was attempted in different solvents (Table 2).
However, transesterification always occurred when alcohols were employed as solvents
while the imine was not stable in a mixture of an ether and water.
Table 2. imine reduction in different solvent systems
Ph

N

CO2Bn

NaBH4
solvent

CO2Bn

BnHN
29

Solvent

Result

Methanol

Transesterification

Ethanol

Transesterification

t-butanol

Transesterification

Isopropanol

Transesterification

THF/water

Imine hydrolysis

Dioxane/water

Imine hydrolysis
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Additionally, the bromination of benzyl crotonate occurred not only on the desired
gamma methyl group but also on the benylic methylene to form 31, when NBromosuccinimide (NBS) was applied (Scheme 10).

CO2Bn
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+
O

30

Ph
Br

31

Scheme 10. Bromination of benzyl crotonate

Based on these results, our synthetic route was modified slightly as shown in Scheme 11
to utilize 32 and 33, the ethyl esters, rather than benzyl esters 29 and 30. Accordingly,
after Michael addition, a hydrolysis of both esters of 35 will be performed.

H2N

PhCHO
Ph

CO2Et

CO2Et Reduction BnHN

N

32

Br

CO2Et

Alkylation

CO2Et

33

CO2Et
Michael addition
BnN

BnN

CO2Et

Hydrolyis
Hydrogenolysis 27
CO2Et

CO2Et

35

34

Scheme 11. Modified synthetic route to prepare 27

In the synthesis of imine 32, two different methods were examined in the reaction of βalanine ethyl ester hydrochloride 36 with benzaldehyde 37 (Table 3). Interestingly, both

32

methods provided 32 with excellent yields. The use of tert-butylmethyl ether (TBME) as
the solvent in the presence of triethylamine (Et3N) for 24 hours gave a quantitative yield.
By contrast, the formation of the imine 32 in CH2Cl2 had a lower yield (92%) and
required a longer reaction time (86 h).

Table 3. Synthesis of imine 32
H 2N

CO2Et + PhCHO

36

Condition

Ph

37

CO2Et

N
32

Reaction condition

Yield

Et3N, TBME, Na2SO4, rt, 24h

100%

Et3N, CH2Cl2, NaSO4, rt, 86h

92%

Several reaction conditions for the reduction of imine 32 to amine 33 were evaluated in
order to optimize the preparation of N-benzyl-β-alanine ethyl ester 33. These conditions
are summarized in Table 4.
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Table 4. Reduction of imine 32
Ph

CO2Et

N

Condition

32

Conditions/reagents
NaCNBH3, glacial acetic

BnHN

CO2Et

33

Reaction time

Result

3 h 35 min

6.7% yield

overnight

Unknown product

H2, Pd/C, Methanol, rt

24 h

Unknown product

NaBH4, Methanol, rt

Overnight

Transesterification

NaBH4, Ethanol, rt

Overnight

29%

NaBH4, Ethanol, rt

40 min

90%

acid, rt
NaCNBH3, glacial acetic
acid, rt

Reaction of 32 with NaBH4 in ethanol at room temperature for 40 mintutes afforded a
90% yield of 33.

The alkylation of amine 33 was carried out in acetonitrile with 4-bromoethyl crotonate in
the presence of potassium carbonate overnight, giving rise to a Michael addition
precursor 34 in a 73% yield after chromatographic purification.

34

The pyrrolidine ring in compound 35 was generated by a cyclization of 34. This
cyclization was realized by an intramolecular Michael addition in which a formed enolate
attacked the α, β-unsaturated carbonyl moiety of precursor 34 to produce a new carboncarbon bond, thus generating the pyrrolidine ring. The formation of the enolate ion was
achieved by deprotonation of 34. Aimed at discovering the optimal reaction condition,
several bases and reaction times were investigated (Table 5).

Table 5. Synthesis of pyrrolidine 35
CO2Et

Condition

BnN

Michael addition

BnN

CO2Et
CO2Et

CO2Et

35

34

Conditions/reagents

Reaction time

Result

TMG, ethanol, rt

Overnight

No reaction

NaH, ethanol, rt

Overnight

No reaction

LiHMDS, dry THF, -78oC

3h

No reaction

LiHMDS, dry THF, -78oC-rt

3h

39%

LiHMDS, dry THF, -78oC-rt

25 min

79%

35

This investigation showed both 1, 1, 3, 3-tetramethylguanidine(TMG) and NaH were not
strong enough as bases. Conversely, lithium hexamethyldisilazide (LiHMDS) in dry THF
was capable of deprotonating compound 34, generating a lithium enolate which
ultimately cyclized to the desired pyrrolidine ring. This investigation also discovered that
the reaction time affected the yield. It was necessary to quench the reaction as soon as 34
was consumed as monitored by TLC. Otherwise, numerous by productes are produced,
resulting in a lower yield. An optimal 79% yield was obtained using LiHMDS in dry
THF with a 25 min reaction time.

The hydrolysis of the Michael adduct 35 was carried out refluxing 1N HCl solution
overnight, followed by the hydrogenolysis under H2 (48psi) in the presence of Pd/C,
affording the final product 27 in a 75% two steps overall yield.

Through analysis of the 700 MHz 2D NOESY NMR spectra, the relative configuration of
compound 27 was determined to be trans. NOESY correlations which confirm this
assignment are shown in Figure 7. The proton Ha is correlated with proton Hc2 while the
proton Hb has a cross peak with protons Hd1. Those correlations reveal that Ha and Hc2
are on the same face, and that Hb and Hd1 are located on the same face. Also, the protons
Hc2 and Hd2 were found to be correlated. Both Hc1 and Hc2 attach to a same carbon,
indicating that they should lie on the opposite faces. Same rule can be applied to Hd1 and
Hd2 which share a same carbon. Accordingly, Hc2 and Hd1 are on the different faces since
Hc2 and Hd2 have a cross peak. Therefore, Ha and Hb reside on the opposite faces. As
such, the relative configuration of compound 27 was assigned as trans.
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Hd1

CO2H
Hb

Hc1

HN

Hd2 Hc Ha
2

CH2CO2H

Figure 7. Relative configuration of 4-(carboxymethyl)pyrrolidine-3-carboxylic acid 27.
Important NOE correlations are indicated with arrows.

Based on this NOE spectrum, we may also conclude that the Michael adduct 35 has a
trans relative configuration as 27 does. As a consequence, on the basis of the discussion
above, an optimal synthetic route for 27 can be summarized in Scheme 12.

H2N

PhCHO

CO2Et
36

CO2Et
BnN

Et3N
TBME
100%

Ph

LiHMDS

BnN

Dry THF
-78oC-r.t.
CO2Et
34

CO2Et

N
32

CO2Et

NaBH4
EtOH
90%

Hydrolysis
HCl
CO2Et
Reflux

79%

CO2Et

BnHN
33

BnN

Br

CO2Et
K2CO3
CH3CN
73%

CO2H

Hydrogenolysis

CO2H

Pd/C, H2(48psi)
H20

HCl

Two Steps
75%

35
CO2H

HN
HCl

CO2H
27

Scheme 12. Synthesis of trans-4-(carboxymethyl)pyrrolidine-3-carboxylic acid 27
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The binding of compound 27 was tested in AMPA, Kainate, NMDA and chloride
dependant glutamate binding sites (Figure 8). However, in light of the affinity of 25 for
the chloride dependant glutamate binding site, the absence of binding for 27 was
surprising. This suggests that the nitrogen at position 2 of aza kainoid 25 may be
responsible for its affinity in the chloride dependant glutamate binding site. This would
also suggest that the known unsubstituted trans-2-carboxy-3-pyrrolidineacetic acid
(CPAA) 38, may have the affinity in the chloride dependant glutamate binding site.

Percent specific
Radioligand binding

120

in AMPA
in GLUTCL
in kainate
in NMDA

100
80
60
40
20
0
-9

-8

-7

-6

-5

-4

Log concentration M

Figure 8. The affinity of compound 27 evaluated in AMPA(■), Kainate(▼) , NMDA(♦)
and chloride dependant glutamate(▲) binding sites.

2.2 Synthesis of trans-2-carboxy-3-pyrrolidineacetic acid (CPAA)
CPAA 38 is a known compound for which numerous syntheses have been published
[Yoo, S.; Lee, S. and Kim, N. 1988] [Karoyan, P. and Chassaing, G. 2002][Oba, M. et al.
2009]. A single study [Tsai, C. et al. 1988] reported that 38 has no affinity for the kainite
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receptor. Therefore, we proposed to synthesize 38 in racemic form and determine its
affinity for the chloride dependant glutamate receptor.
CO2H
N
H

CO2H
38

Karoyan P. and his associates [Karoyan, P. and Chassaing, G. 2002] utilized a zinc
enolate

cyclizaiton

to

stereoselectively

synthesize

(2S,

3R)-3-

(carboxymethyl)pyrrolidine-2-carboxylic acid, a method that we chose to employ with
some modifications.

2.2.1 Experimental results and discustion
In the effort to synthesize the trans CPAA in racemic form, a cyclization precursor 39
(Scheme 13) was prepared. The preparation of 39 began with an esterification, giving rise
to ethyl glycine 40 in 93% yield. The ethyl glycine 40 reacted with benzaldehyde 37 to
give an imine intermediate which was reduced with NaBH4 to form an amine 41. The
overall yield for the two steps was 81%. The alkylation of this amine 41 with 4bromobutene provided the cyclization precursor 39 in a 64% yield.

39

H2N

CO2H

SOCl2
EtOH
-20oC-rt-reflux

H2N

CO2Et
40

93%yield

i. PhCHO, TBME,
Na2SO4, Et3N
ii. NaBH4, EtOH

Ph

H
N

CO2Et

41
81%yield

Br
K2CO3
CH3CN
reflux

N
Ph

CO2Et
39

64%yield

Scheme 13. Synthesis of cyclization precursor 39

Following the procedure of Karoyan P. et al. [Karoyan, P. and Chassaing, G. 2002],
compound 39 was deprotonated by Lithium diisopropylamide (LDA) to form a lithim
enolate. Transmetallation with ZnBr provided the zinc enolate which went through a
cyclization to produce the cis pyrrolidine intermediate in the form of a new Zinc enolate.
After a second transmetalation with the addition of THF soluble CuCN/2LiCl salts, an
organozinccopper species was produced and reacted with tosylcyanide, leading to
compound 42. This process is extremely sensitive to water, requiring the use of dry
reagents and solvents in anhydrous conditions. The hydrolysis and hydrogenolysis of
compound 42, followed by purification using ion-exchange chromatography, gave the cis
CPAA 43. The epimerization was realized by heating cis CPAA 43 in water at 190oC for
12 hours, producing a mixture of trans/cis CPAA (80/20), as determined by 1H NMR
(Scheme 14).
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ZnBr2, -78oC to rt
N
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ii. CuCN/2LiCl,0oC
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Ph
39

33%yield

CO2H
i. HCl 6N, reflux
ii. H2/Pd then
Dowex 50-X8

CO2Et

N
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H2O
sealed tube
190oC

CO2H
N
H

(±)
43

CO2H +
(±)

CO2H
N
H

CO2H
(±)

20:80

45%yield

Scheme 14. Synthesis of a mixture of tran/cis CPAA

However, the unsuccessful attempts to separate trans CPAA from its cis isomer by
recrystallization, prompted us to prepare their Cbz protected derivatives (Scheme 15)
with an intention of obtaining the pure trans derivative by chromatography. The mixture
of trans/cis CPAA (80/20) was treated with benzyl chloroformate, to form the Cbz
protected cis/trans CPAA mixture, followed by an esterification with ethanol in the
presence of 4-dimethylaminopyridine (DMAP) and 1-ethyl-3-(3-dimethylaminopropyl)
carbodiimide hydrochloride (EDC), leading to the mixture of Cbz protected cis/trans
CPAA derivatives in an overall 43% yield. Preparative HPLC was employed to afford
only the trans derivative. The hydrogenolysis and hydrolysis of this trans derivative gave
the desired trans CPAA 38 in racemic form.
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Scheme 15. Preparation of tran CPAA 38 from a mixture of trans/cis CPAA (80/20)

The binding of the trans CPAA 38 was tested in AMPA and chloride dependant
glutamate binding sites (Figure 9). But, surprisingly, no affinity for any of those receptors
was observed.
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Figure 9. The affinity of trans CPAA 38 evaluated in AMPA(■) and chloride dependant
glutamate(▲) binding sites.
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2.3 Conclusion
The lack of the affinity of both compound 27 and the trans CPAA 38 for chloride
dependant glutamate binding site suggested that both nitrogens in aza kainoid 25 are
involved in hydrogen bonding, thus significantly enhancing the affinity of 25 in the
chloride glutamate binding site.
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3. Synthesis of isoxazolidine analog of kainic acid
3.1 1, 3 dipolar cycloaddtion as a key step realizing desired absolute configurations

CO2H

Ph 3

4

HN O 5

CO2H

28

Isoxazolidine analog 28 of kainic acid has the S, S and S absolute configurations at its
three chiral centers. Those configurations will be generated by a key reaction: 1, 3
Dipolar cycloaddition of an unsaturated α, β ester with a nitrone. 1, 3 dipolar
cycloaddition

requires

consideration

of

regioselectivity

as

well

as

relative

stereoselectivity (exo/endo) and absolute stereoselectivity (diastereofacial). The
regioselectivity has been discussed above in the introduction section and on the basis of
the assumption that the α, β-unsaturated ester (the dipolarophile) will favor the interaction
of the HOMO of the dipolarophile with the LUMO of the nitrone (the dipole), so the
terminal oxygen atom of the nitrone is predicted to attack the α-carbon of the ester.

Assuming this regioselectivity, the exo/endo selectivity is outlined in Figure 10.
According to the two transition states, the endo pathway will yield a 3, 4-cis relative
configuration, as preferred in our synthetic plan for 28. On the other hand, the exo route
will form a 3, 4-trans configuration.

44

PG
N
H

PG

O

R1O2C
R2

N

R1= benzyl

H
R2

R1O2C
endo pathway

PG= protecting group

O

CO2R1

R2= phenyl

R1O2C

exo pathway

Figure 10. Exo/Endo selectivity in synthesis of 29 given a proposed regioselectivity

Given the selected endo pathway, the diastereofacial selectivity may offer two different
enatiomers, determined by the attack of the dipole on the Re/Si face of the unsaturated
ester at α position. Si facial approach will give the S, S and S absolute configurations at
position 3, 4 and 5, whereas the Re face attack will afford a R, R and R absolute
configurations at position 3, 4 and 5. Chiral catalysts may be applied to achieve the
desired diastereofacial selectivity as mentioned in the introduction.

3.2 Model study of 1, 3 dipolar cycloaddtion between trans-dibenzyl glutaconate and
benzyl protected nitrone
With the aim of confirming those hypotheses regarding to the regioselectivity and
stereoselectivities, a model study, 1, 3 dipolar cycloaddition of benzyl protected nitrone
44 with dimethyl glutaconate 45 (Scheme 16) was launched. However, the undesired
regioselectivity along with the production of multiple diastereomers suggested the need
to revise the synthetic plans for 28. Additionally, as mentioned in the experimental
design, our concerns regarding the protecting groups of nitrones also came to mind. Most

45

nitrones are protected by alkyl, phenyl and benzyl groups. Unfortunately, no method for
the removal of the former two groups from the generated isoxazolidines has been
devised. Hydrogenolysis can cleave the benzyl group, but it will also result in the
reductive cleavage of the N-O bond of the isoxazolidine ring.

N
H

CH3ReO3
Urea.H2O2
CH3OH
79%yield

N
O
44
MeO2C

N2
Neat

Ph

60oC
4 days
17%yield

Bn

CO2Me
CO2Me
N O

MeO2C
45

Scheme 16. 1, 3 Dipolar cycloaddition between benzyl protected nitrone 44 and dimethyl
glutaconate 45 yields undesired regioselectivity and multiple diastereomers.

3.3 An alternative synthetic plan
Thus, a new synthetic plan (Scheme 17) for 28 was proposed. A chiral oxazolidinone
diene derivative could react with a Boc protected nitrone using Lewis acids as catalysts to
provide an isoxazolidine cycloadduct. Upon the removal of the oxazolidinone moiety, a
Kowalski reaction was planned to insert a methylene group between the isoxazolidine
ring and the carboxylate group. A new carboxylic acid group could be formed through
the oxidation of the vinyl group. The deprotection of the Boc protected amine by TFA
will lead to the target compound 28.
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Scheme 17. Revised synthetic plan of isoxazolidine analog 28

3.3.1 Influences of Lewis acids on 1, 3 dipolar cycloaddition

In this synthetic plan, the 1, 3 dipolar cylcoaddition is still a key reaction whose transition
state is controlled by the frontier molecular orbitals (FMO) of dipoles and dipolarophiles,
i.e. The HOMO dipolarophile can react with the LUMO dipole while the LUMO
dipolarophile with the HOMO dipole [Gothelf, K. V. and Jorgensen, K. A. 1998]. On the
basis of Sustmann’s classification, 1, 3-dipolar cycloadditions were divided into three
types, according to the relative FMO energies between the dipole and the dipolarophile
(Figure 11) [Sustmann, R. 1971] [Houk, K. N. et al. 1973].
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Energy

Dipole

Dipolarophile

Dipole

Type I

Dipolarophile

Type II

Dipole

Dipolarophile

Type III

Figure 11. Sustmann’s classification of 1, 3-dipolar cycloaddtions: type I, a
HOMOdipole-LUMOdipolarophile interaction; type II, interaction of both HOMOdipoleLUMOdipolarophile and LUMOdipole-HOMOdipolarophile; type III, a LUMOdipoleHOMOdipolarophile interaction.

In this classification, the type I involves HOMO dipole-LUMO dipolarohile interactions
in the transition state.; in type II, the similarity of the dipole and dipolarophile FMO
energies suggests that the 1, 3-dipolar cycloadditon can undergo either the HOMO
dipole-LUMO dipolarohile interaction or the HOMO dipolarophile-LUMO dipole
interaction; in type III, the dominant interaction is that between the LUMO dipole and the
HOMO dipolarophile..

The 1, 3 dipolar cycloaddition of nitrones are normally classified as type II, therefore, its
transition state can be controlled by either HOMO dipole-LUMO dipolarophile
interaction or HOMO dipolarophile-LUMO dipole interaction. For instance, in Scheme
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18, when N-methyl-C-phenylnitrone reacts with methyl acrylate, this 1, 3 dipolar
cycloaddition is controlled by the HOMO dipole-LUMO dipolarophile, whereas the 1, 3
dipolar cycloaddition between the same nitrone and vinyl ether is controlled by the
LUMO dipole-HOMO dipolarophile [Gothelf, K. V.; Jorgensen, K. A. 1998][Perez, P. et
al. 2003].

N

110oC, 21h
O

+

Ph

N
Ph

CO2CH3

99%

N O
Ph

70oC, 48h
O

+

OBu

99%

CO2CH3

N O

OBu

Ph

Scheme 18. 1, 3 dipolar cycloaddition of N-methyl-C-phenylnitrone with methyl acrylate
and vinyl ether, performed by Perez, P. et al.. [2003]

The presence of a Lewis acid influences the FMO-energy of nitrones or dipolarophiles.
For instance, the coordination of a Lewis acid, such as BF3.OEt2 or AlCl3 to a nitrone,
lowers both HOMO and LUMO energies of the nitrone. Thus, if the nitrone acts as
electrophile in the cycloaddition, one would predict that this coordination would
accelerate the reaction. But, according to Gothelf, K. V. et al., on a model 1, 3-dipolar
cycloaddition of benzylidenemethylamine N-oxide with styrene, the transition state
energy calculations indicated that the coordination between a Lewis acid like BF3.OEt2 or
AlCl3 and a nitrone increased the transition state energy of 1, 3 dipolar cycloaddition, as
compared to a reaction without the involvement of Lewis acid [Gothelf, K. V. and
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Jorgensen, K. A. 1994]. Therefore, the catalytic effect of these Lewis acids is difficult to
predict. On the other hand, Gothelf and his associate found that dipolarophile 3-acyl-1,
3-oxazolidin-2-one 46 can chelate titanium (IV) complexes. This chelation between the
conjugated carbonyls of 46 and the Lewis acid (titanium complexeses), considerably
accelerated the cycloaddition reaction [Gothelf, K. V. and Jorgensen, K. A. 1994].
O
R

O
N

O

46

The proposed application of Lewis acids will also have a significant influence on the
stereoselectivities. The exo/endo selectivity dictating the relative configuration of the
newly formed carbon-carbon bond is affected by the coordination of dipolarophile to a
Lewis acid catalyst [Hein, J. E.; Julttin, P. G. 2005][Gothelf, K. V. et al. 1996]. Hence,
the desired cis relative configuration between position 3 and 4 of our target compound 28
can be accomplished by the correct choice of Lewis acids.

The regioselectivity of the oxazolidinone substituted ene-ones towards nitrones is the
same as that of dimethyl glutaconate. The exo/endo selectivity using oxazolidinone
substituted ene-ones as dipolarophiles can be depicted in Figure 12. From those transition
states, the exo selectivity will give a 3, 4-cis relative configuration in the generated
isoxazolidnes, as preferred for our target compound 28. By contrast, the endo selectivity
will form a 3, 4-trans relative configuration.
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Figure 12. Exo/Endo selectivity using oxazolidinone alkene dipolarophiles

A study by Gothelf, K. V. et al. [Gothelf, K. V. et al. 1996] established that the
octahedral Ti(O-iPr)2Cl2 Lewis acid catalyst favored the exo pathway and tetrahedral
metal complex catalysts favored the endo pathway.

The diastereofacial preference of the dipolarophile dictates the formation of the absolute
configurations of the major product. Selectivity is governed by both chelation of the
carbonyls of the dipolarophile to the metal catalyst [Hein, J. E.; Julttin, P. G. 2005][Faita,
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G. et al. 2001], and the steric effect of a substituent (the directing group) in the
oxazolidinone ring (Figure 12). In the synthetic route (Scheme 17), the phenyl directing
group controls the direction of approach of the dipole (opposite the phenyl group)
towards the Cα-Si face, favoring the formation of the S configuration at position 4 of the
isoxazolidine ring.

3.3.2 1, 3 dipolar cycloaddtion between 3-crotonyloxazolidinone and benzyl protected
nitrone using different Lewis acids

3-Crotonyloxazolidinone, an achiral dipolarophile 47 was prepared through a
nucleophilic acyl substitution reaction of deprotonated 2-oxazolidone and crotonyl
chloride in dry THF in a 55% yield (Scheme 19).
O

O
O

+
Cl

HN

n-BuLi
O

Distilled THF
55%yield

O
N

O
47

Scheme 19. Preparation of achiral dipolarophile 47

Intending to find optimal reaction conditions for this 1, 3 dipolar cycloaddition, a model
study (Table 6), using this simplified and achiral dipolarophile 47, was examined with
several different Lewis acids.
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Table 6. 1, 3 Dipolar cycloaddition between oxazolidinone derivative 47 and benzyl
protected nitrone using different Lewis acids
O

O
N

+
O

Bn

O
N

Ph

O
Bn N

Lewis acid

Ph

N
O

O
O

exo cycloadduct

Lewis acid

Solvent/temperature

BF3.(OEt)2 (1.2eq)

Dry CH2Cl2/r.t.

AlCl3(1.2eq)

Dry CH2Cl2/r.t.

ZnCl2(1.2eq)

Dry CH2Cl2/r.t.

Sc(TfO)3 (1.2eq)

Dry CH2Cl2/r.t.

CeCl3(1.2eq)

Dry CH2Cl2/r.t.

CuBr2 (1.2eq)

Dry CH2Cl2/r.t.

SnCl2.2H2O(1.2eq)

Toluene/55oC

Time
7
days
5
days
5
days
2
days
2
days
2
days
5
days

ZnCl2(1.2eq)

Toluene/55oC

1 day

Sc(TfO)3 (0.1eq)

Dry CH2Cl2/r.t. with
4A Molecular Sieve
(M.S.)

3
days

Sc(TfO)3 (0.1eq)

Dry CH2Cl2/r.t. with
6eq water

3
days

TiCl4(0.2eq)

Dry CH2Cl2/r.t. with
4A M.S.

7
days

Ti(i-OPr)2Cl2
(0.2eq)

Dry CH2Cl2/r.t. with
4A M.S.

4
days
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+

O
Bn N
Ph

N
O

O
O

exo cycloadduct

Result
No reaction (NR)
NR
NR
NR
NR
NR
NR
Small amount of product
but most of starting
materials unreacted based
on NMR
Small amount of product
but most of starting
materials unreacted based
on NMR
NR
About 1/3 starting
material remained based
on the NMR
Crude product (exo/endo:
77/23) based on NMR and
after the purification,
exo/endo:9:1
37%yield

This examination of Lewis acids provided several potential catalysts for the proposed 1, 3
dipolar cycloaddition of the chiral oxazolidinone diene dipolarophile. Among them,
however, Ti(i-OPr)2Cl2 gave predominantly the exo cycloadduct with a better conversion,
as determined by comparison with existing NMR data of the exo and endo cycloadducts
[Gothelf, K. V. and Jorgensen, K. A. 1994]. The result that Ti(i-OPr)2Cl2 preferred the
exo pathway is consistent with Gothelf’s finding [Gothelf, K. V. et al. 1996][ Gothelf, K.
V. and Jorgensen, K. A. 1994].

3.3.3 1, 3 dipolar cycloaddition of oxazolidine diene dipolarophile and synthesis of Boc
protected nitrone

Encouraged by this result, an achiral oxazolidinone diene derivative 49 was prepared
(Scheme 20) in a manner similar to the preparation of 47, with a 75% yield in the
substitution reaction between sorbyl chloride 48 and deprotonated 2-oxazolidone.
O
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O

NaOH
O

100%yield

O
OH

O
N

Cl

3 drops DMF
86%yield

O

O

Oxalyl chloride

48

O

n-BuLi
Dry THF
-78oC-25oC
75%yield

O

49

Scheme 20. Preparation of oxazolidinone diene derivative 49

Compound 49 was used in additional model studies (Scheme 21) to examine its utility in
a 1, 3 dipolar cycloaddition with benzyl protected nitrone 44.
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Scheme 21. Model study between diene 49 and benzyl protected nitrone 44

Discouragingly, this reaction did not proceed as expected. The product was not purified
for characterization. However, based on the 1H NMR of crude product, the vinyl methyl
doublet in the dipolarophile shifted from 2 ppm to 1.1 ppm, suggesting that a
cycloaddition or Diels Alder reaction occurred involving the γ, δ double bond. To address
this problem, a new dipolarophile 50 with acetoxymethyl moiety was designed for the
cycloaddition (Scheme 22) with the expectation that the acetyl group could be hydrolyzed
and the resulting alcohol oxidized to the carboxylic acid..
AcO
O
AcO

O
N

O

O
N
+ Boc

O
N
Boc
Ph

Ph
Ph

Ph
50

O
N

O

O
exo cycloadduct

Scheme 22. Proposed 1, 3 dipolar cycloaddition between Boc protected nitrone and
dipolarophile 50

Being aware of that the N-benzyl was not the optimal protecting group, concurrent to the
experiment above, a different nitrogen protecting group was sought. The Boc protected
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hydroxylamine 51 has been reportedly prepared and converted in situ to the
corresponding Boc protected nitrone with the aid of a base, followed by a reaction with a
dipolarophile in a one pot process (Scheme 23) [Gioia, G. 2009]. It should be noted that
the reaction of this N-Boc protected nitrone proceeds through a two step polar process
instead of a 1, 3-dipolar cycloaddition, possibly providing the undesired all trans
trisubstituted isoxazolidines as Gioia, G.; et al. obtained. With this consideration as well
as numerous unsuccessful attempts to obtain this hydroxylamine 51, an alternate
approach was taken.
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rt
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Ph
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MeO

O

MeO
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OMe

Ph
O N

O
OMe
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Scheme 23. Preparation of Boc protected hydroxylamine 51 and its conversion for 1, 3
dipolar cycloadditioin, performed by Gioia, G. et al.

3.3.4 1, 3 dipolar cycloaddition of aminal protected nitrones
3.3.4.1 Aminal protected nitrones and their corresponding synthetic plans

A search of the literature revealed two aminal protected nitrones, oxane protected ntirone
52 [Abiko, A. 1995] and glycosylnitrone 53 [Cicchi, S. et al. 2003], which have been
used in 1, 3-dipolar cycloadditions. Each of these nitrones incorporates an amino
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protecting group that can be removed under mild acidic conditions after the
cycloaddition. This addresses the issue of reductive cleavage of the isoxazolidine N-O
bond caused by hydrogenolysis when utilizing benzyl protecting group.
O
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Ph

O

O

Ph
O
53
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Nitrone 52 was previously prepared by Abiko, A. [Abiko, A. 1995] without a detailed
preparation procedure. As this nitrone 52 will be formed in racemic form, a chiral
oxazolidinone derivative 54 was designed to as the dipolarophile, with the expectation
that the stereoselectivity will be controlled predominantly by this dipolarophile.
Therefore, nitrone 52 could be used as shown in Scheme 24. In this approach, the oxane
protected ntirone 52 will react with a chiral oxazolidinone derivative 54 in the presence
of Ti(i-OPr)2Cl2 to form a desired exo cycloadduct with the 3S, 4S and 5S absolute
configurations.
O

Ph
O
N
Ph

O
52

+

O

N

O

OAc
O

Ti(i-OPr)2Cl2
exo pathway

N

O 5 OAc
4

Ph 3
O
N
O

54

O
Ph

Scheme 24. Proposed cycloaddition between nitrone 52 and oxazolidinone derivative 54

Nitrone 53 could be used as shown in Scheme 25. In this approach, the dipole 53, instead
of the achiral dipolarophile 55, possesses a chiral auxiliary to influence both
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diastereoselectivity and enatioselectivity. Consequently, this cycloaddition may produce a
predominant diastereomer, hopefully, with the desired configurations at positions 3, 4 and
5.
O
O
O

O
N
Ph

+

O
53

exo pathway

O
OAc

O
55

O
O

OAc
O 5
N
3
4
Ph
O
O

Scheme 25. Proposed cycloaddition of nitrone 53 and crotonate derivative 55

3.3.4.2 Synthesis of oxane protected nitrone and achiral dipolarophile

The planned application of Ti(i-OPr)2Cl2 and the oxazolidinone moiety in chiral
dipolarophile 54, took a priority in attempting the synthetic route of Scheme 24 because
the Ti(i-OPr)2Cl2 has proven to be an exo selectivity catalyst in chelating to the carbonyl
of oxazolidinone moiety.
An achiral dipolarophile 58 was prepared using the multi-step sequence shown below
(Scheme 26). It is worth noting that both allylic bromide and acyl chloride moieties of
intermediate 56 are suseptible to attack by the activated oxazolidone. Therefore, the
deprotonated oxazolidone was transferred very slowly into a flask of excess 56 via a
cannula at -78oC. The formed product 57 was treated with silver acetate in glacial acetic
acid, converting to the achiral dioplarophile 58 with precipitation of AgBr.

58

O
O

HN

NBS(1.02eq)
CCl4
Benzoyl peroxide(0.02eq)
OH
Br
Reflux

O

SOCl2
CCl4
o
OH 60 C

O
Br

Cl
56

O
Br

O
N

57

O

AgOAc
AcOH
100oC
47%yield

O

O
AcO

n-BuLi
Dry THF
-78oC-r.t.
51%yield

O
N

O

58

Scheme 26. Preparation of achiral dipolarophile 58

Scheme 27 illustrates the synthetic route for the preparation of nitrone 52. Benzaldehyde
oxime was reduced with NaCNBH3 in a 95% yield to form N-benzylhydroxylamine 59.
Reacting with hemiactal 60, compound 59 was converted to an equilibrating mixture of
oxane protected hydroxylamine 61 and an open-chain nitrone 62 with a ratio of 2.2:1,
determined by NMR. The nitrone 52 was formed by oxidizing the mixture of 61 and 62
using MnO2. Due to the decomposition of nitrone 52 on silica gel and no feasible solvents
discovered for recrystallization, pure nitrone 52 was not obtained. As a result, the focus
was shifted to study nitrone 53 and its cycloaddition.

59

N

OH

NaCNBH3
Methanolic HCl
95%yield

N
H

OH

59
2N HCl

O

O

N
O
OH
61

Et3N
Na2SO4
CH2Cl2
70%yield

OH

75%yield
60
2.2:1
N
O

MnO2
CH2Cl2

N HO
OH
62

O

not pure

Scheme 27. Synthesis of nitrone 52

3.3.4.3 1, 3 dipolar cycloaddition between glycosyl protected nitrone and its
corresponding dipolarophile

A simple synthesis (Scheme 28) offered dipolarophile 55 in an 81% yield from ethyl 4bromocrotonate.
O
Br

OEt

AgOAc
ACOH
Reflux
81%yield

O
AcO

OEt
55

Scheme 28. Preparation of dipolarophile 55

The synthesis of nitrone 53 resulted from a mult-step sequence (Scheme 29). In the
presence of concentrated H2SO4, the diol of D-ribose reacts with acetone to form the
acetonide, compound 63. NaBH4 was used to reductively open the hemiacetal of 63 to
form a triol. This newly formed vicinal diol is subjected to oxidative cleavage by NaIO4,
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to give an aldehyde which immediately reacts with the gamma hydroxyl group to
generate the hemiacetal 64. Benzylhydroxylamine 59 reacts with 64 in the presence of
pyridine to give glycosyl protected hydroxylamine 65 in a 92% yield. Glycosylnitrone 53
was obtained by the oxidation of 65 using MnO2.

OH

OH
D-Ribose

H2SO4/Acetone
r.t.
100%yield

O
OH
O

NaBH4
Methanol
0oC

OH
OH
O

O

O

NaIO4
H2O/MeOH
r.t..

O
OH
O

O

64
63

HN OH
Dry Pyridine
r.t.
92%yield

Ph
N OH

O

Two steps
69%yield

MnO2
CH2Cl2
81%yield

O

O

O
O

O
N

Ph

O
53

65

Scheme 29. Preparation of nitrone 53

The 1, 3 dipolar cycloaddition between the glycosylnitrone 53 and the crotonate
derivative 55 was examined in two different conditions (Table 7). The use of Ti(iOPr)2Cl2 did not facilitate the cycloaddition, probably because dipolarophile 55 lacks the
ability to chelate the titanium as the oxazolidinone derivatives. However, the reaction of
chiral nitrone 53 with 55 refluxing refluxing toluene under N2 afforded only one
diastereomer 66 in a 44% yield.
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Table 7. 1, 3 Dipolar cycloaddition between nitrone 53 and a crotonate derivative 55
O

O
O

O

O

N

+

Ph

OAc

O

Condition

N

O
O

O

Ph

55

53

66

Reaction condition
TiCl2(i-OPr)2/Dry CH2Cl2/r.t. 5days
Toluene/Reflux 6 days

O

OAc

O
O

Result
No reaction based on NMR
44%yield

Unfornately, the correlation between Ha and Hb in the NOESY spectra (Figure 13)
indicated that this cycloaddition proceeded through an endo pathway, giving rise to a
cycloadduct with trans relative configuration between positions 3 and 4, not the preferred
cis configuration. This result also demonstrates the importance of the chelation between
the metal catalyst and oxazolidinone substituted dipolarophiles, in affecting the exo/endo
selectivity of 1, 3-dipolar cycloaddition

O
O

O
O

OAc

Ha

N
5
3
4
Ph
O
O

O
O
O

N

Hb

CO2Et

H
Ph CH2OAc

O

66

Figure 13. Structure and relative configurations of compound 66. Important NOE
correlations are shown with arrows.
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3.3.5 Diphenylmethine protected nitrone and a series of investigations

Nitrone 67, which is protected by diphenylmethine group, was synthesized by
Hashimoto, T. and his coworkers and applied to 1, 3 dipolar cycloaddition (Scheme 30)
[Hashimoto, T. et al. 2007] .
OH
NH

Bezaldehyde
CH2Cl2
rt

O
N

Ph

Ph

CHO
Ph

chiral Ti catalyst
o

Ph

CH2Cl2, 0 C OHC
24h

Ph

67

Ph
N

O

68
single isomer
endo selective

Scheme 30. Preparation of nitrone 67 and its application in 1, 3 dipolar cycloaddition to
form isoxazolidine 68, performed by Hashimoto, T. et al.

Hashimoto reported the removal of the diphenylmethine protecting group from
isoxazolidines 68 and 70 (Shemes 32 and 33) using two different approaches. The first
method involved the treatment of diphenylmethine protected isoxazolidine 69, with NBS
in CH2Cl2, followed by acidic hydrolysis using p-TsOH (Scheme 31) [Hashimoto, T. et
al. 2007].
Ph
Ph

Ph

Ph
N

OHC
68

O

NaBH4

Ph

Ph
N

MeOH, rt
96% HO
69

O

i. NBS
CH2Cl2/H2O
rt
ii. p-TsOH
CH3CN/H2O
rt

Ph

H
N

O

HO

Scheme 31. Removal of diphenylmethine protecting group using NBS and p-TsOH,
performed by Hashimoto, T. et al.
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The second methods involved the hydrolysis of diphenylmethine protected isoxazolidine
70, with concentrated HCl in methanol. The deproteceted isoxazolidine was then
hydrogenolyzed to a 1, 3 amino alcohol (Scheme 32) [Hashimoto, T. et al. 2008].

Ph
Ph

NaClO2, NaH2PO4
2-methyle-2-butene,tBuOH
H2O

Ph
N

O

OHC

Ph
Ph

Ph
N

O

conc. HCl
MeOH

HO2C
70

68

Ph
MeO2C

H
N

O

Raney N2, H2
MeOH

H2N

CO2Me

Ph

Scheme 32. Removal of diphenylmethine protecting group using conc. HCl in methanol,
performed by Hashimoto, T. et al.

We concluded that the isoxazolidine ring could be deprotected while maintaining the N-O
bond by using a diphenylmethine protecting group, prompting the design of a 1, 3 dipolar
cycloadditon using nitrone 67 and a chiral dipolarophile having a directing group R, with
the intention of obtaining a deprotectable exo cycloadduct which has the desired absolute
configuration through the use of the TiCl2(O-i-Pr)2 catalyst (Scheme 33).
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Ph
Ph

O
O
N

Ph

+

AcO

Ph

Ph
TiCl2(i-OPr)2

O
N

O

R

N
3
Ph
O

OAc

O
5
4
N

O

O
R

R= isopyropyl or benzyl

Scheme 33. Proposed 1, 3 dipolar cycloaddition of nitrone 67 to form an isoxazolidine
with a specific configuration

Based on the literatures [Liu, S.; Yu, Y. and Liebeskind, L. S. 2007][Sivappa, R. et al.
2007], preparation of nitrone 67 (Scheme 34) began with an oxime formation 71 (88%
yield) from benzophenone and hydroxylamine, followed by a reduction to give a
hydroxylamine 72 in an excellent 99% yield. In terms of the method described by
Hashimoto, T. [Hashimoto, T. et al. 2007] with some modifications, compound 72 was
converted to the diphenylmethine protected nitrone 67 (81%).

O
+

NH2OH.HCl

OH
N

Pyridine
methanol
rt
overnight

71
OH
NH

88%yield

Bezaldehyde
CH2Cl2
rt
4h

O
N

Ph

Ph

Ph

72

67

99%yield

81%yield

Scheme 34. Synthesis of nitrone 67
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NaCNBH3
Methanol
6N HCl
0oC-rt
4h

Prior to launching the designed cycloaddition, several model reactions were investigated.

i.
Exo/endo selectivity
The targeted compound 28 has the same relative configurations as exo cycloadducts,
therefore exo selectivity is preferred. The main goal of this model study is to determine
the exo/endo selectivity of nitrone 67 in 1, 3 dipolar cycloaddition by using different
Lewis acids. Two dipolarophiles 47 and 73 were employed in this study. The synthesis of
crotonate dipolarophile 47 has been mentioned above. As shown in Scheme 35, the
acrylate dipolarophile 73 was prepared as previously described [Hird, A. W. and
Hoveyda, A. H. 2003].
O
O

+
Cl

HN

O

NaH
CH2Cl2
40%yield

O

O
N

O

Scheme 35. Preparation of acrylate dipolarophile 73

As for the exo selectivity investigation, Ti(i-OPr)2Cl2, a catalyst which has been studied
in the 1,3 dipolar cycloaddition between benzyl protected nitrone 44 and crotonate
dipolarophile 47 in table 6, was examined. As anticipated, this catalyst provided the exo
products as the major diastereomers. The reaction (entry 3 in Table 8) between nitrone 67
and dipolarophiles 47 produced an exo predoninant mixture with a 2.6/1 ratio of exo
adduct 74 to endo adduct 75 as determined by NMR. After chromatographic purification,
the ratio increased to 8.6:1 with a 61% purified yield. The pure exo cycloadduct 74 can be
recrystallized from anisole/henxane (1:4). The acrylate derivative 73 as the dipolarophile
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provided a lower selectivity (entry 2 in Table 8) with a mixture of exo adduct 76 and
endo adduct 77 (1.7/1).

Table 8. Various dipolarophiles and Lewis acids in 1, 3 dipolar cycloaddition of nitrone
67
O

R

O
N

O

+ Ph
Ph

O
N

Ph
Ph

O

R

N

Lewis acid
Dry CH2Cl2
4A M.S.

Ph
O +

N

Ph
Ph

O
rac-exo

73 R = H
47 R = CH3
58 R=CH2OCOCH3
78 R=Phenyl

O

O

R

N
Ph

O

N

Ph
O

O

rac-endo
76&77 R = H
74&75 R = CH3
79&80 R=CH2OCOCH3

Entry

R

Lewis acid

Condition

Exo/endoa

yield
(exo/endo)

1

CH3

No catalyst

Room
temperature/9days

No reaction

No reaction

2

H

TiCl2(i-OPr)2

Room
temperature/9days

1.7:1(76/77)

43% (3:1) b

3

CH3

TiCl2(i-OPr)2

Room
temperature/9days

2.6:1(74/75)

61% (9:1) b

4

CH3CO2CH2

TiCl2(i-OPr)2

Room
temperature/9days

3.4:1(79/80)

66%c

5

CH3CO2CH2

TiCl2(i-OPr)2

Reflux/9days

2.9:1(79/80)

48% (3.1:1) b

6

Ph

TiCl2(i-OPr)2

Room
temperature/14days

No reaction

No reaction

7

Ph

TiCl2(i-OPr)2

Reflux/5days

No reaction

No reaction

8

H

Sn(OTf)3

Room
temperature/9days

1:1.1(76/77)

60%c

67

9

H

Sn(OTf)3

Reflux/9days

1:1.0(76/77)

72% (1:1) b

10

CH3

Sn(OTf)3

4oC/9days/no stirring

1:2.6(74/75)

62%c

12

CH3

Sn(OTf)3

Room
temperature/9days

1:5.2(74/75)

92%c

13

CH3

Sn(OTf)3

Room
temperature/about 5
months

1:10.5(74/75)

98%c

14

CH3

Sn(OTf)3

Reflux/9dadys

1:3.8(74/75)

70%(0:1) b

15

CH3CO2CH2

Sn(OTf)3

Room
temperature/9days

only found endo
adduct

15%c

16

CH3CO2CH2

Sn(OTf)3

Reflux/9dadys

only found endo
adduct

14%c

17

CH3

MgI2phenanthroline

Room
temperature/9days

1:1.7(74/75)

6%c

18

CH3

MgI2phenanthroline

Reflux/9days

1:1.1(74/75)

19%c

a, determined by 1H NMR of crude products; b, after purification; c, determined by 1H NMR of the crude
product

The examination of the endo selectivity was also performed in the precence of MgI2Phenantroline or Sc(OTf)3. Surprisingly, MgI2-Phenantroline (entry 17 and 18 in Table 8)
whose chelation with crotonate dipolarophile 47 provided a major endo adduct in 1, 3
diopar cycloaddition with phenyl protected nitrone [Desimoni,G. et al. 1999], gave a poor
yield in the reaction with 67 either at room temperature or in refluxing CH2Cl2. This
probably resulted from the steric constraints of both bulky MgI2-Phenantroline and bulky
protecting group. On the other hand, the use of Sc(OTf)3, an endo selective catalyst,
provided the endo cycloadduct 75 in refluxing CH2Cl2 in a 70% yield in the cycloaddition
reaction of 47 and 67 (entry 14 in Table 8). Interestingly, the reaction of acrylate
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dipolarophile 73 in refluxing CH2Cl2 yielded cycloadducts with a poor selectivity as 1:1
exo to endo adducts were obtained (entry 9 in Table 8).

It should be noted that the assignment of exo and endo isomers were based on the
coupling constants between H3 and H4 in the isoxazolidine rings [Huisgen, R. et al.
1969][Gothelf, K. et al. 1996]. The exo adduct with a cis relative configuration between
H3 and H4, has a larger H3-H4 coupling constant than the endo isomer which has a trans
relative configuration between H3 and H4. As exo adduct 74 and endo adduct 75 as an
example, according to our NMR experiments, the cycloadduct 74 with 10.4 Hz coupling
constant between H3 and H4 was therefore identified as exo adduct while isomer 75 with
6.0 Hz coupling constant was then assigned as endo adduct.

ii.
Various dipolarophiles in 1, 3 dipolar cycloaddition with nitrone 67
To further understand the influence of substituents in 3-acyl-1, 3-oxazolidin-2-one 46
toward the 1, 3 dipolar cycloaddition with nitrone 67, dipolarophiles 78 bearing a phenyl
substituent prepared (Scheme 36) based on the literature [Andrade, C. K. et al. 2003],
together with dipolarophiles 47, 73 and 58, was studied.

O

O

Ph

+ HN
OH

O

DCC
DMAP
CH2Cl2
95%

O

Ph

N

78

Scheme 36. Preparation of cinnamate dipolarophile 78
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As shown in Table 8, electronic effects of the dipolarophile influence the exo/endo
selectivity: the higher electronegativity a substitent has, the higher the diastereoselectivity
will be. For instance, in the presence of TiCl2(i-OPr)2, an exo catalyst, the exo selectivity
increased from 1.7:1 to 2.6:1 to 3.4:1 as the substituent changed from a hydrogen to
methyl group to acetoxymethyl group (entry 2, 3 and 4 in Table 8), respectively. A
similar result was observed in the endo selective cycloaddition using Sn(OTf)3 as the
catalyst in refluxing CH2Cl2. As such, the endo selectivity jumped from 1:1 to 3.8:1 with
the change of substituent from a proton to methyl group (entry 8 and 14 in Table 8).
Those results are in a good agreement with the finding of Badoiu, A. and Kundig, E. P.
[Badoiu, A. and Kundig, E. P. 2012] who determined that the formed exo diastereomer
increased with the increasing electron-withdrawing character of substituent in
dipolarophiles in non-catalyzed

1, 3 dipolar cycloaddition reaction between 4-

(trifluoromethyl)benzylidene methylamine N-oxide and 3, 5-substituted isoxazolidines.
On the basis of Table 8, the size of substituents at the β carbon of 3-acyl-1, 3-oxazolidin2-one affects the 1, 3 dipolar cycloadditon reaction, that is to say that the larger
substituent made this cycloaddition more difficult to proceed. For example, in the
presence of TiCl2(i-OPr)2, when the substituent was a small group such as a proton and
methyl group, the cycloaddition can be achieved at room temperature. But when the
substituent is a larger group like an acetoxymethyl group, the reaction had to be
performed under refluxing CH2Cl2 to complete the reaction.

When the size of the

substituent continued to increase as it was a phenyl group, this cycloaddition cannot be
carried on even under refluxing CH2Cl2.
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The 1, 3 dipolar cycloaddditions between achiral dipolarophile 58 and nitrone 67 without
the involvement of any chiral auxiliary (entry 4 and 5 in Table 8) also serves as a model
study to investigate the feasibility of proposed 1, 3 dipolar cycloaddition (Scheme 33).
The evaluation of the reaction conditions in this model study showed that at room
temperature, even after 9 days, significant amount of starting materials are present. This
reaction, therefore, was carried out on refluxing CH2Cl2 for 9 days, resulting in a 3.1/1
ratio of exo to endo selectivity with the complete consumption of starting reagents. After
chromatographic purification, a 48% yield was obtained.

iii.
Deprotection
The removal of the protecting group without reductive cleavage of the isoxazolidine ring
is an essential step in the synthesis of isoxazolidine analogs of kainic acid. Our first
attempt involved treatment of the exo adduct 74 with N-bromosuccinimide in CH2Cl2,
followed by acidic hydrolysis, according to the method described by Hashimoto, T. et al..
[2007]. Unfortunately, in our hands, the method gave a dihydroisoxazole final product
81, likely through the aminal intermediate (Scheme 37)
O

O

74

HN
HO
Ph

N
O

O

Ph

O

81

Scheme 37. Attempted deprotection of 74 with NBS
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Aimed at preparing the unprotected isoxazolidines, several different conditions were
studied. Attempts at deprotection using methanolic HCl (4:1) or tifluoromethylsulfonic
acid in TFA also failed, returning only starting material or an intractable mixture. On the
other hand, refluxing the diphenylmethine protected isoxazolidine 74 in CH2Cl2 with 2.5
equivalents of Et3SiH in the presence of TFA provided deprotected isoxazolidine 82
(Table 9, entry 3).

Table 9. Investigation of the deprotection of isoxazolidines
Ph

O

R

N

O

N

Ph
Ph

conditions

O

6
7
8
9
10

Substrate
76
77
74
75
74
74
74
74
74
74

R

HN
Ph

O

76&77 R = H
74&75 R = CH3

Entry
1
2
3
4
5

O

O

N
O

O

84&85 R = H
82&83 R = CH3

Conditions

Et3SiH (2.5 eq), TFA, CH2Cl2,reflux 2.5 h
Et3SiH (2.5 eq), TFA, CH2Cl2,reflux 2.5 h
Et3SiH (2.5 eq), TFA, CH2Cl2,reflux 2.5 h
Et3SiH (2.5 eq), TFA, CH2Cl2,reflux 2.5 h
i. NBS (1.1 eq) ,CH2Cl2/H2O,rt. ii. pTsOH,CH3CN/H2O,rt
TfOH, anisole,0oC-rt
TfOH, TFA, 0o
TfOH, TFA, 0oC-rt
MeOH:HCl (4:1), room temp
MeOH:HCl (4:1), reflux 30 min

Outcome
100% 84
87% 85
93% 82
83% 83
47% yield of 81
No reaction
No reaction
Intractable mixture
No reaction
No reaction

Encouraged by this result, we extended this method to several different diphenylmethine
protected isoxazolidines 75, 76 and 77. This method provided the corresponding Nunsubstituted isoxazolidines 83, 84 and 85 in yields range from 83 to 100%.
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The benzyhryl protecting group is not particularly common, but has found applications in
the protection of aziridines [Patwardhan, A. P. et al. 2005], azetidines [Laurent, M. et al.
2003], in particular β-lactams, and in the selective protection of uracil nitrogens [Wu, F.
et al. 2004]. Deprotection is typically achieved through catalytic hydrogenation or
vigorous acid treatment. More novel methods involve oxidation to the benzhydrol either
with NBS followed by hydrolysis [Laurent, M. et al. 2003] or ozone treatment followed
by NaBH4 reduction [Patwardhan, A. P. et al. 2005], although yields are poor (~50%) in
the later method.

A single report describes the reductive cleavage of the N-

diphenylmethine group with Et3SiH [Neumann, W. L. et al. 1991]. Although another
report noted the instability of the N-diphenylmethine group during reductive cleavage of
t-butyl esters using Et3SiH [Kirincich, S. J. et al. 2009]. We have found that the
diphenylmethine protecting group may be readily cleaved from isoxazolidines by
reduction with Et3SiH while maintaining the sensitive N-O bond.

iv.

Aymmetric synthesis

The use of a chiral Lewis acid catalyst is one approach to the induction of
enantioselectivity. Chiral 1, 1’-binaphthol complexes of titanium have been successfully
applied in the enantioselecitve addition of nucleophiles to carbonyl groups [Duthaler, R.
O. and Hafner, A. 1992]. However, when using this catalyst in the 1, 3 dipolar
cycloaddion of phenyl protected nitrone with dipolarophile 47, Gothelf K. V. et al.
[Gothelf. K. V. 1994] found only an 8% ee of the exo adduct. Later, Hoshimoto, T. et al.
[Hoshimoto, T. et al. 2007] reported that cycloadducts of the diphenylmethine protected
nitrone 67 were obtained with a higher enantioselectivity in the asymmetric 1, 3 dipolar

73

cycloaddition reaction. This made us wonder if chiral 1, 1’-binaphthol complexes of
titanium could generate high enantioselectivity in the 1, 3 dipolar cycloaddition of
diphenylmethine protected nitrone 67 with dipolarophile 47. Thus, chiral 1, 1’binaphtholtitanium complex was prepared as previously described [Gothelf. K. V. 1994]
and used as a catalyst in the 1, 3 dipolar cycloaddition of 67 and 47 (Scheme 38). The
crude product was obtained in 67% yield with 1.1:1 exo/endo selectivity. However, it
only induced about 6% ee of exo adduct purified through radial chromatography and
recrystallization, as determined by 1H NMR using Eu(hfc)3 as chiral shift reagent.

OH
+
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TiCl2(i-OPr)2

-2 i-PrOH

O
TiCl2
O

CH2Cl2

1, 1'-binaphtholtitanium (IV) complex
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O
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O
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Dry CH2Cl2
4A M.S.
Reflux
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Ph

N
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O

O

exo

O
N
Ph

O

N

Ph
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Scheme 38. Application of chiral 1, 1’-binaphtholtitanium complex

Another method to induce a high enantioselectivity/diastereoselectivity is the
employment of chiral auxiliary. A model study was undetaken to identify a chiral
auxiliary which can significantly enhance the enantioselectivity of the 1, 3 dipolar
cycloaddition to predominantly form the diastereomer with the desired 3S, 4S and 5S
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absolute configuration. We investigated two chiral auxiliaries, the oxazolidone
derivatives 86 & 87 with either isopropyl directing group or benzyl directing group, both
prepared using the procedure developed for the preparation of 47. The dipolar
cycloaddition between dipolarophile 86 and nitrone 67 gave a 3.1/1 mixture of exo to
endo cycloadducts after 9 days of reaction, with a 58% yield of exo cycloadduct after
purification isomers. Meanwhile, the dipolar cycloaddition between dipolarophile 87 and
nitrone 67 afforded a 3.3/1 ratio of exo to endo isomers after 11 of days reaction, with a
41% yield of exo cycloadduct after purification (Table 10). Thus it was determined that
dipolarophiles 86 and 87 gave similar exo/endo selectivity. However, dipolarophile 86
was judged to be superior as its use resulted in a higher yield in a shorter reaction time as
compared to 87. We therefore chose the isopropyl directing group over the benzyl group.

Table 10. Investigation of chiral auxiliaries using dipolarophiles 86 and 87
O

O
N

O + Ph
Ph

R

O
N

Ph
Lewis acid
Dry CH2Cl2 Ph
Ph
4A M.S.
Temperature

O

Ph

N
Ph
R

O
N

O
N

+
O

Ph
R

O
exo

O

Ph

endo

N

O

O

88 (exo) R = CH(CH3)2
89 (exo) R = Bn

86 R = CH(CH3)2
87 R = Bn

Entry
1

R
Isopropyl

Lewis acid
TiCl2(i-OPr)2

2

Ph

TiCl2(i-OPr)2

3

Isopropyl

Sn(OTf)3

4

Isopropyl

Sn(OTf)3

a, determined by 1H NMR of crude products

Condition
Exo/endoa
Yield
Room
3.1/1
58% (pure
temperature/9days
exo 88)
Room
3.3/1
41%(pure
temperature/11days
exo 89)
Room
No
No reaction
temperature/9days
reaction
No reaction No reaction
Reflux/9days
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v.

Determination of the absolute configuration using Mosher’s method

Radial chromatography afforded the major exo isomer 88 but the absolute configuration
of the three new stereocenters remained unknown. Several examples of the asymmetric
syntheses of isoxazolines can be found in the chemical literature. However, the methods
used to determine absolute configuration involved either X-ray crystallography [Cicchi,
S. et al. 2003][Blanarikova-Hlobilova, I. et al. 2003] or conversion of the cycloadduct to
a known compound for which the sign of optical rotation is known. [Gothelf K. V. et al.
1996]. However, the former may not be helpful since not all of the molecules of interest
will form a uniform crystal and the cost can be very high [Allen, D. A. et al. 2008]. The
latter has more limitations because it requires a known compound with the assigned
absolute configurations for comparsion, which is not always available. We therefore
sought a simple and straightforward method to determine the absolute configuration of
isoxazolidines. Mosher demonstrated that the determination of chiral amines and alcohols
can

be

realized

by

the

analysis

of

1

H

or

19

F

NMR

spectra

of

methoxy(trifluoromethyl)phenylacetyl (MTPA) derivatives of those compounds [Dale, J.
A. and Dull, D. L. 1969][Dale, J. A. and Mosher, H. S. 1973]. Since then, the application
of Mosher derivatives for the purpose of determining absolute configurations of chiral
amines and alcohols has become common place. For the determination of chiral primary
amines, the experiments of Kusumi and Kakisawa [Kusumi, T. et al. 1991][Allen, D. A.
et al. 2008] indicated the dominant conformation of the resulting amides (Figure 14) in
which the α-proton of the amine, the carbonyl oxygen and the trifluoromethyl gourps are
coplanar and syn. In Figure 14, because the R1in S-MTPA amide is on the same side of
the phenyl of the MTPA moiety, the protons of R1 group are shielded by the phenyl.
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Therefore in 1H NMR spectra, the chemical shifts of those protons are upfield as
compared to the protons of R1 in R-MTPA amide which is on the different side of the
phenyl group. Same result can be observed between the protons (upfield) of R2 group in
R-MTPA amide and the protons (downfield) of R2 group in S-MTPA amide. Through the
assessment of the chemical shift differences Δδ (δS-δR) of the protons of R1 group
between S-MTPA and R-MTPA amides as well as the Δδ of the protons of R2 group
between S-MTPA and R-MTPA amides, the assignment of the absolute configuration of
the chiral amine moiety can be achieved [Kusumi, T. et al. 1991][Allen, D. A. et al.
2008]. In the favored conformation shown in Figure 14, the α-CF3 group experiences
anisotropic deshielding by the amide carbonyl. However, if R1 or R2 are bulky, the
anisotropic deshielding may be affected. For example, if R1 is bulky and is larger than R2,
the interation of R1 and the bulky phenyl in S-MTPA amide, which can be either steric,
electronic, or both, will force the α-CF3 group out of the coplanarity with the carbonyl
group. Consequently, α-CF3 will no longer experience the deshielding effect of the
carbonyl and the chemical shift for the 19F signal of the S-MTPA amide will be lower as
compared with R-MTPA amide whose bulky R1 is on the opposite side of the phenyl
substituent [Sullivan, G. R. et al. 1973].

R2 H
N
R1
H

MeO

Ph

S CF3
O

R2 H
N
R1
H

Ph

OMe

R CF3
O

Figure 14. S-MTPA amide and R-MTPA amide
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The use of Mosher’s amide derivatives for the determination of absolute configuration
has been principally applied to primary amines. Application of this approach to cyclic
amines has been limited in the past and the use of Mosher derivatives for determination
of absolute configuration of chiral isoxazolidines has not been reported. This is in part
due to the difficulty of preparing N-unsubstituted isoxazolidines. As we have been able to
deprotect our isoxazolidines cycloadducts, we wished to develop a model for the
determinination of the absolute configuration of isoxazolidines using the Mosher
derivatives. Travers and Rauk [Khan, M. A. et al. 1982][Rauk, A. et al. 1983] studied a
number of MTPA amides of piperidines. The MTPA amide of cis-2, 6dimethylpiperidine exists predominantly as two slowly interconverting diastereomeric
rotamers (Figure 15), which appear as two distinct species in the 1H NMR spectra. This
observation suggests the potential for the assignment of absolute configuration of cyclic
amines by way of the Mosher derivatives. Likewise, the Mosher derivatives of 2substituted pyrrolidines reportedly also esist as two slowly interconverting rotamers as
observed by 1H NMR [Hoye, T. R. and Renner, M. K. 1996][Vidal, P. et al. 2007].

N

N
Ph

O

OMe
CF3

MeO
Ph

O
CF3

Figure 15. Two rotamers of cis-2, 6-dimethylpiperidine MTPA amide

With these earlier studies in mind, we undertook an analysis of the Mosher derivative of
cycloadduct 88. Two exo adducts of 88 may potentially be produced (diastereomers 88a
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and 88b), resulting from attack on diastereotopic faces of the dipolarophile 86. Although
the 1H NMR spectra of the purified exo adduct appeared to be a single diastereomer, we
cannot make this assumption. Therefore, after deprotection, the exo adduct 88 was
converted to the R-MTPA amide derivative by reacting with S-MTPA-Cl (Scheme 39).
The ratio of isomers was determined by 19F NMR.
O

O R

Ph
N

S

Ph
Ph

S
88a

O

O

O S
N

Ph
Ph

R
R
O
88b

N

O

Et3SiH
TFA
CH2Cl2
Reflux
81%

O
H3CO

O
90a

O

O
HN
Ph

O

N

pyridine
CCl4
rt

N
O

O

O

91a

Cl

O
N

Ph

CF3

S
O

and/or

CF3

R
O

N

Ph

O

and/or
Ph

HN

N

H3CO

O

O

O

and/or
H3CO

CF3

R
O

N

O

O
N

Ph

90b

O

91b

O

Scheme 39. Preparation of R-MTPA amide; the S configuration of S-MTPA-Cl was
changed to the R configuration of the generated MTPA amide
In CDCl3, two peaks were observed in the 19F NMR spectra with a ratio of 1 to 2 (Figure
17a). There are two possible explanations for the observation of two peaks in the

19

F

NMR. The first possibility is that there are two different diasteromers 91a and 91b. The
other explanation is that there is a single isomer which exists as two slowly
interconverting rotamers (Figure 16), consistent with the coexistence of syn and anti
rotamers of cyclic amine MTPA derivatives such as piperidine and pyrrolidines [Khan,
M. A. et al. 1982][Rauk, A. et al. 1983][Vidal, P. et al. 2007].
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Figure 16. Two possible romators of 91a or 91b
When the 19F NMR was acquired in d6-acetone, the peak ratio changed to 1 to 4 (Figure
17b). Because the diastereomer ratio would not be solvent dependent, we concluded that
the two peaks represent slowly equilibrating amide rotamers. This observation, that there
are only two equilibrating rotamers, also suggests the presence of a single diastereomer,
either exo 88a or exo 88b. Those two exo adducts have the opposite absolute
configurations for the isoxazolidine ring substituents.

Intending to determine the absolute configuration of the exo, the deprotected exo adduct
90 was also derivatized with racmic Mosher’s acid chloride for comparison of their
and 1H NMR spectra. The

19

19

F

F NMR spectra of the Mosher derivative prepared from

racemic MTPA showed four peaks, two of them coincident with those observed in the RMTPA amide obtained from the reaction of 90 with S-MTPA-Cl (Figure 17C). We
conclude that the two new peaks belong to the S-MTPA amide produced by the reaction
of 90 with R-MTPA-Cl.
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a.

19

b. 19F NMR spectrum in d6-acetone

F NMR spectrum in CDCl3

Major R-derivative
Major S-derivative

Minor S-derivative
Minor R-derivative

c. 19F NMR spectrum in CDCl3
Figure 17. 19F NMR spectra of MTPA amide; a, 19F NMR spectra of R-MTPA amide, determined
in CDCl3; b, 19F NMR spectra of R-MTPA amide, determined in d6-acetone; c, 19F NMR spectra
of R-MTPA amide and racmic MTPA amides, determined in CDCl3, red peaks from R-MTPA
amide and blue peaks from racmic MTPA amide

To investigate the conformational properties of the isoxazolidine ring in the
diastereomeric Mosher’s amides, we conducted a conformational search using the MMX
force field within program Batchmin. As observed with the piperidine and pyrrolidine
MTPA amides, and supported by our 19F NMR spectra, these calculations predict that the

81

isoxazolidine MTPA derivative may adopt two conformations. The E and Z forms are
assigned, in our case, on the basis of the relationship between the Cα-CO and the N-O
bonds. For both the R and S derivatives, the E rotamer is lower in energy than the Z form
as shown in Figure 18.
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S-MTPA
amide

F3C

O

Major (E)

Minor (Z)

OMe

O

Ph
F3C
O

N

F3C

O

Ph

Ph
R

Major (E)

MeO Ph
F C
O
R-MTPA 3
N
amide
O

O

N
OMe
Ph

R

O
F3C
MeO

Ph

Major (E)

O
S-MTPA
amide
R

O

O
F3C

O

Ph

Ph
R

Major (E)

Minor (Z)

S and R- MTPA amides of 90a

R

Minor (Z)

Ph
N

O

Ph

R

Ph

F3C
MeO

N

N
OMe
Ph

O

R

Minor (Z)

S and R- MTPA amides of 90b

O
R=
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Figure 18. Conformational preferences of S and R MTPA amides of 90a (left) and 90b
(right), according to MMX force field
On the basis of these computational results, the relative chemical shifts of diagnostic
signals in the 19F, 1H NMR of R and S-MTPA amides may be predicted, resulting in the
assignment of the absolute configuration. The diagnostic peaks (Figure 19C) in 1H NMR
were assigned with the assistance of COSY experiments.
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a, 1H NMR spectrum of R-MTPA amide

Ph

b, 1H NMR spectrum of racemic-MTPA amide

CF3
O

MeO

Ha
Hb

N
O

Ph

Hb(S-Major)

HcR

Hb(R-Major)

R=R-MTPA amide
S=S-MTPA amide

Hc(S-Major)

Methoxy
(S-Major)

Methoxy
(R-Major)

Hc(S-Minor)
Ha(S-Major) Hb(S-Minor)
Hc(R-Minor)
Hb(R-Minor)

Hc(R-Major)

Ha(R-Minor)

Ha(R-Major)

Ha(S-Minor)

c, overlap of 1H NMR spectra of R and racemic-MTPA amide
Figure 19. 1H NMR spectra of the product of MTPA amide; a, 1H NMR spectrum of R-MTPA
amide; b, 1H NMR spectra of the product of racemic-Mosher MTPA amides; c, 1H NMR spectra
of R-MTPA amide and racmic MTPA amides, blue peaks from R-MTPA amide and red peaks
from racemic MTPA amides
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According to MMX force field, in the E rotamers, the MTPA-phenyl groups of R and S
MTPA amides are on the same side of the isoxazolidine ring. This results from the
preference for the α-OCH3 of the major E rotamer of the R-MTPA amide to adopt an
eclipsed arrangement with the C=O double bond, whereas the major E rotamer of the SMTPA amide adopts the more typical conformation in which the α-CF3 is eclipsed with
the C=O double bond. Beacause of the preference for different conformations, the
protons on the isoxazolidine ring in both the R and S derivatives experience similar
anisotropic shielding effects of the phenyl group. It is therefore, not helpful to examine
relative chemical shifts of the ring protons of the major rotamers to determine absolute
configuration. However, the chemical shifts of methoxy and trifluoromethyl groups may
be affected by the phenyl of isoxazolidine moiety. If the single diastereomer is 88a, in the
E rotamer of the R-MTPA amide, the α-CF3 is shielded by the phenyl of the isoxazolidine
while in the E rotamer of the S-MTPA amide, the α-CF3 group experiences anisotropic
deshielding by the amide carbonyl since the MTPA-phenyl and the isoxazolidine-phenyl
are on the different side. Additionally, in the E rotamer of the R-MTPA amide, the
methoxyl group experiences anisotropic deshielding by the amide carbonyl while in the E
rotamer of the S-MTPA amide, the methoxyl group is shielded by the phenyl of the
isoxazolidine. These analyses suggest that the chemical shift for the 19F α-CF3 signal of
the R-MTPA amide must be upfield as compared with S-MTPA amide and the chemical
shift of the protons of methoxyl in the R-MTPA amide must be higher than in the SMTPA. We indeed observed these results in 19F NMR spectra (Figure 17c) and 1H NMR
spectra (Figure 19c and summarized in Table 11). If the single diastereomer is 88b, the
chemical shift differences of α-CF3 and methoxyl groups between the E rotamers of the
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R-MTPA amide and the S-MTPA amide will conflict with the experimental results. This
demonstrated that the single diastereomer is 88a which has 3S, 4S and 5R absolute
configurations in the isoxazolidine ring.

Table 11. Analysis of the major rotamers of MTPA amides of 90a
R-MTPA amide of 90a
Ph
MeO

Major rotamer (E)

O

N
Ph

C=O
Isoxazolidine-Ph
δ ppm(expected)
δ ppm(experimental)

CF3
Not affected
shielded
lower
-71.8

S-MTPA amide of 90a

CF3
O
R

OCH3
deshielded
Not affected
higher
3.60

CF3
deshielded
Not affected
Higher
-71.4

OCH3
Not affected
Shielded
Lower
3.35

The inspection of the minor (Z) rotamers of the R- and S-MTPA isoxazolidine amides is
perhaps more informative and more generally applicable. The conformation of the Z
rotamers of both the R- and S-MTPA derivatives is more similar to that of acyclic amides
and a similar analysis may be applied. In the Z rotamer of R-MTPA of 90a (Figure 18,
left), the Hb and Hc are shielded by the MTPA-phenyl, whereas in the Z rotamer of SMTPA of 90a, only Ha is shielded by the MTPA-phenyl (Table 12). In addition, because
the bulky MTPA-phenyl and isoxazolidine-phenyl are on the same side of the
isoxazolidine ring in the Z rotamer of the S-MTPA amide, the α-CF3 will be shifted away
from co-planarity with the C=O, thus it will no longer be subjected to the anisotropic
deshielding of the C=O group. The chemical shift for the 19F α-CF3 signal of the S-MTPA
amide must be lower as compared with R-MTPA amide. In other words, the relative
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chemical shifts of the α-CF3 groups of the Z rotamers should be opposite that of the E
rotamers. These results were all observed in 1H NMR spectra (19c) and 19F NMR spectra
(17c)

Table 12. Analysis of minor rotamers of MTPA amides of 90a
R-MTPA amide of 90a
O

Minor rotamer (Z)

α-Ph
δ ppm

F3C
MeO

Ha
Not
effected
5.0

N
Ph c
Ph

S-MTPA amide of 90a
O

O

F3C

a
b

Ph
R

Hb

Hc

Ha

Shielded

Shielded

Shielded

3.4

5.25

2.8

O
N
a
OMe c
b
Ph
R

Hb
Not
effected
4.5

Hc
Not
effected
5.45

Oxazolidinone chiral auxiliaries provide high diastereofacial discrimination in a wide
variety of reactions including 1, 3-dipolar cycloadditions. On the basis of the discussion
regarding the Si/Re facial selectivity in cycloadditions, it can be reliably predicted that the
cycloadduct resulting from Si face approach is preferred since it arises from the attack of
the nitrone on the dipolarophile from the face opposite the directing group. Therefore,
this diastereomer can be predicted to have the 3S, 4S and 5R absolute configurations in
the isoxazolidine ring, which is consistent with the absolute configuration of 88a.

Encouraged by the results of model studies, a chiral dipolarophile 92 was synthesized
(Scheme 40), in a route similar to the preparation of achiral dipolarophile 58. (R)-4isopropyloxazolidin-2-one 93 reacted with excess intermediate 56 to γ-bromocrotonyl
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oxazolidinone derivative 94 (34%), which was converted to the dipolarophile 92 in a 61%
yield, by treatment with silver acetate.
O
O

NBS(1.05eq)
CCl4
Benzoyl peroxide(0.02eq)
OH
Br
Reflux

SOCl2
O
CCl4
o
60
C
OH

Br

Cl
56

O
Br

O
N

O

AgOAc
AcOH
100oC
61%yield

O

O

AcO

N

94

N
H
(93)

O

O

n-BuLi
Dry THF
-78oC-r.t.
34%yield

O

92

Scheme 40. Synthesis of chiral dipolarophiles 92

The 1,3-dipolar cycloaddition between nitrone 67 and a chiral dipolarohile 92 was
launched for evaluation (Table 13).

Table 13. 1, 3 dipolar cycloaddition of nitrone 67 with chiral dipolarophile 92 at
refluxing CH2Cl2 and CHCl3
O
AcO

O
N

O

O
N

+ Ph

Ti(i-OPr)2Cl2
4A M.S.
9d

Ph

Refluxing solvent

Ph

AcO
Ph

O
N

O

Ph
Ph

N
O

92

Reflux solvent

Ratio of exo to endo

Yielda

CH2Cl2

3.2:1

32%

CHCl3

2.0:1

26%

a, determined by 1H NMR of crude products

87

O

However, even after 9 days this reaction is not complete in either refluxing CH2Cl2 or
refluxing CHCl3. Yields, as determined by 1H NMR of the crude product, were 32% in
refluxing CH2Cl2 and 26% in refluxing CHCl3. In refluxing CH2Cl2, the ratio of exo to
endo was 3.2:1 while in refluxing CHCl3, the ratio dropped to 2.0:1 due to the increased
reaction temperature. Attempts to separate exo and endo adducts by radial
chromatography failed. The exo and endo adducts were separable by preparative HPLC
but according to the 1H NMR spectra, 10% of exo adduct seemed to go through
isomerization during the purification.

3.4 Future synthetic plan for preparing isoxazolidine analogs of kainic acid 28
Although the 1, 3 dipolar cycloaddition between nitrone 67 and dipolarohile 92 in
refluxing CH2Cl2 proceeded in poor yield, it may yet be a promosing approach for
preparing the target compound 28. The determination of enantiomeric excess of exo 88
using the Mosher derivatives suggested the exo adduct formed in the reaction of 67 and
92 may be a single diastereomer of the desired absolute configuration. The inseparable
mixture of exo and endo adducts could be used directly in the next reaction and the goal
of separating them may be realized after the removal of oxazolidinone moiety. If not, the
removal of diphenylmethine, followed by the protection with Boc group, could be
conducted to attempt the separation. A different reaction solvent like dry toluene may
improve the percent yield of the cycloaddition reaction, but perhaps at the expense of
stereoselectivity.
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Scheme 41. Future plan for the Synthesis of 28

Therefore, our future plan for synthesizing 28 (Sheme 41) is similar to the previous plan
depicted in Scheme 17. After the 1, 3 dipolar cycloaddition of 67 with 92, the
oxazolidinone moiety will be removed with a hope of separating exo and endo adducts. A
Kowalski reaction will then be employed to insert a methylene group between the
isoxazolidine ring and the carboxylate group. A new carboxylic acid group could be
formed through the oxidation of the formed hydroxyl group. The deprotection of the
diphenylmethine protected amine, followed by hydrolysis, will lead to the target
compound 28.
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4. Conclusion
Kanic acid, an analog of glutamic acid, posseeses pronounced biological properties due to
its silimar structure to glutamic acid. During the past three decades or so, numerous
investigations on its biological activities and its synthesis have been conducted. However,
selective formation of the three tetrahedral stereocenters of the pyrrolidine ring poses a
great challenge to the synthetic efforts. As a result, attention was shifted to the functional
mimics of kainic acid that may be readily synthesized with control over absolute and
relative stereoselectivity. Aza kainoids analog is one such example. The unsubstituted aza
analog of kainoids has demonstrated its ability to function as an ionotropic glutamate
receptor agonist by inducing an inward current in Aplysia californica neuronal cells and
showed its affinity to the chloride dependent glutamate binding site. This observation
promted the question of the importance of the presence of one nitrogen or both nitrogens
in the pyrazolidine skeleton of aza kainoid analog for binding to glutamate receptors.
Thus,

two

different

pyrrolidine

analogs

of

kainic

acid,

trans-4-

(carboxymethyl)pyrrolidine-3-carboxylic acid 27 and trans-2-carboxy-3-pyrrolidineacetic
acid 38, were synthesized. The demonstrated lack of affinity of both pyrrolidine analogs
towards the chloride dependant glutamate binding site indicated that both nitrogens of the
aza kainoid analog 25 are involved in hydrogen bonding to the receptor, significantly
enhancing the affinity for the chloride dependant glutamate binding site.

Isoxazolidine analogs of kainoids are another family of potential functional mimics of
kainic acid. Thereotically, the isoxazolidine skeleton can be constituted directely via a
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simple 1, 3 dipolar cycloaddition without a need of a further reduction. This avoided the
trouble of the isomerization caused by the reduction in the synthesis of aza kainoid
analogs. However, due to the sensitive N-O bond of isoxazolidines, the preparation of Nunsubstituted isoxazolidines is problematic when common protecting groups such as
alkyl, phenyl and benzyl groups are employed. Additionally control over absolute
configuration in the isoxazolidine analogs must be achieved. Therefore, the asymmetric
synthesis of 1, 3 dipolar cycloaddition for the purpose of obtaining the desired absolute
configurations of isoxazolidine analogs was pursued. Unfortunately, glycosyl protected
nitrone whose protecting group can be removed under mild acidic condition, gave rise to
an undesired endo selective isoxazolidine.

However, a series of investigations

domenstrated that diphenylmethine protected nitrone could be a good substrate for the
synthesis of isoxazolidine analogs of kainoid. Model studies showed that the exo/endo
selectivity in the 1, 3 dipolar cycloaddition of the diphenylmethine protected nitrone with
3-acyl-1, 3-oxazolidin-2-one can be controlled by using different Lewis acid catalysts,
and that the deprotection of diphenylmethine group with the intact isoxazolidine ring left
can be realized by the treatment with Et3Si and TFA in refluxing CH2Cl2. Model studies
revealed that with the involvement of a directing group in dipolarophiles, high
enantioselectivity can be achieved. Although the target isoxazolidine analog 28 was not
obtained, these model studies solved key problems in the synthesis of 28, including a new
deprotection method for preparing N-unsubstituted isoxazolidines without the cleavage of
the weak N-O bond, as well as obtaining the desired diastereomers via the 1, 3 dipolar
cycloaddition reaction. The resolution of these problems makes the synthesis of
isoxazoldines analogs of kainic acid very promosing.
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5. Experimental procedure
1

H and

13

C NMR spectra were obtained using Bruker AVANCE 400 spectrometer.

Abbrevations for signal couplings are as follows: s, singlet; b, broad; d, doublet; t, triplet,
q, quartet and m, multiplet. Melting point of solid samples were performed using MELTEMP melting point apparatus uncorrected. Analytical thin layer chromatography (TLC)
was performed on 0.25 mm Analtech silica gel GHLF plates. The chromatograms were
visualized under UV light or by staining with iodide. Radial chromatography was
performed on a chromatotron using plates coated with silica gel 60 PF254 containing
gypsum. All air sensitive reactions were carried out under nitrogen environment. Unless
otherwise noted, all common reagents and solvents purchased from commercial sources
were used without further purification. All glassware used for moisture-sensitive
reactions were either oven dried overnight or flame-dried.

Preparation of dry solvents and reagents
(1) dry THF was prepared by distilling over calcium hydride; (2) dry ethyl ether was
distilled from sodium metal/benzophenone when the solution becomes blue; (3) dry
methylene chloride was distilled out into a flask with 4A molecular sieve on the bottom
after being refluxed with calcium hydride for 1 hour; (4) dry ZnBr2 (in dry ethyl ether):
ZnBr2 was heated under flame until it melted and then cooled to room temperature under
vacuum and placed under nitrogen atmosphere. A magnetic stirrer and dry ethyl ether
were added and the solution is stirred until complete dissolution of the zinc salts; (5) dry
CuCN/2LiCl (in dry THF): CuCN and 2 equivalents LiCl was heated by flame under
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vacuum while being stirred by a magnetic stirring bar. The salts mixture was then cooled
to room temperature under vacuum and placed under nitrogen atmosphere before adding
dry THF. The suspension was stirred until it became a dark green solution.

Preparation of trans-dibenzyl glutaconate
Dimethyl glutaconate (mixture of 83% trans and
17% cis, Fluka) was purified two times by flash
chromatography on a silica column using solvent

O

O
O

O

gradient 5%-20% ethyl acetate in hexane to obtain trans dimethyl glutaconate (>97%).
Trans dimethyl glutaconate (10. 0243 g, 0.063 mol) was dissolved in 100 ml H2O and
NaOH (5.8974 g, 0.147 mol) was added. The reaction mixture was stirred under room
temperature for 2.5 hours and 10% sulfuric acid was added until pH <2.0. The resulting
solution was extracted by ethyl acetate (3x150 ml). The combined organic extracts were
dried by Na2SO4, filtered and concentrated in vacuo, to give glutaconic acid (7.1013 g,
0.055 mol, 86% yield) as white crystals. A 250ml round bottom flask equipped with a
Dean-Stark trap was charged with glutaconic acid (5.9156 g, 0.046 mol), benzyl alcohol
(9.6 ml, 0.093 mol), toluene (60 ml) and TsOH·H2O (187.7 mg, 1 mmol). The stirred
mixture was refluxed for 4 hours and then cooled to room temperature. Upon the removal
of the solvent in vacuo, the residue was purified by chromatography on silica gel
(hexane/EtOAc 9:1) to give trans-dibenzyl glutaconate (11.1582 g, 0.036 mol, 79%
yeild) as colorless oil. 1H NMR was consistent with literature [Gioia, C. et al. 2009]. 1H
NMR (CDCl3, 400 MHz) δ 7.41-7.35 (m, 10H), 7.15 (dt, 1H, J=15.6, 6.8 Hz), 6.05 (d,
1H, J=15.6 Hz), 5.22 (s, 2H), 5.19 (s, 2H), 3.33 (dd, 2H, J = 7.2, 1.2 Hz).
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Preparation of ethyl 3-(benzylideneamino)propanoate (32)
To a 250 ml round bottom flask were added β-alanine ethyl
ester hydrochloride (7.6390 g, 0.05 mol), tert-butylmethyl

O
O

N

ether (TBME, 42 ml), anhydrous sodium sulfate (4.2795 g,
0.03 mol), and distilled benzaldehyde (5.5947 g, 0.05 mol) sequentially. The stirred
suspension was cooled to 0oC in an ice bath and triethylamine (10 ml, 0.07 mol) was
added dropwise over 10 min. The reaction suspension was then allowed to warm to room
temperature and stirred for 24 hours. The mixture was filtered over a pad of Celite and
evaporated under reduced pressure to give the desired imine (10.1913 g, 100% yield) as
yellow oil which can be used directly in the next step. 1H NMR (CDCl3, 400 MHz) δ
8.34 (s, 1H), 7.73 (m, 2H), 7.41(m, 3H), 4.14(q, 2H, J=7.2 Hz), 3.90(dt, 2H, J=6.8, 1.6
Hz), 2.74(t, 2H, J=6.8 Hz), 1.24(t, 3H, J=7.2 Hz,); 13C NMR (CDCl3, 100 MHz) δ 172.0,
162.3, 136.1, 130.7, 128.6, 128.2, 60.4, 56.7, 35.5, 14.2

Preparation of ethyl 3-(benzylamino)propanoate (33)
A 500ml round bottom flask was charged with ethyl 3(benzylideneamino)propanoate (11.5685 g, 0.056 mol) and

O
O

NH

100 ml EtOH. The mixture was cooled to 0oC in an ice bath
and sodium borohydride (4.3016 g, 0.113 mol) was introduced in three portions over 10
min. The reaction mixture was stirred at room temperature for further 40 min and was
quenched by slowly adding saturated NaHCO3 solution (140 ml). After filtration, the
resulting solution was extracted by ethyl acetate (3x200 ml). The combined organic
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extracts were dried by Na2SO4, filtered and concentrated in vacuo to give the desired
product (10.5090 g, 90% yield) as yellow oil. 1H NMR (CDCl3, 400 MHz) δ 7.427.24(m, 5H), 4.16(q, 2H, J=7.2 Hz), 3.83(s, 2H), 2.92( t, 2H, J=6.4 Hz), 2.55(t, 2H, J=
6.4 Hz), 1.27( t, 3H, J=7.2 Hz);

13

C NMR (CDCl3, 100 MHz) δ 172.7, 140.2, 128.4,

128.1, 126.9, 60.4, 53.7, 44.5, 34.8, 14.2. HR-MS(ESI/APCI) calcd for: C12H18NO2
(MH+): 208.1332, found: 208.1333

If the reaction time is too long, which will lead to the formation of impurities,
chromatography (petroleum ether/EtOAc 1:1) can be employed to afford the pure amine.

Preparation of (E)-ethyl 4-(benzyl(3-ethoxy-3-oxopropyl)amino)but-2-enoate (34)
To a 100ml round bottom flask were added 3(benzylamino)propanoate (2.0672 g, 0.010 mol),
acetonitrile (35 ml) and potassium carbonate (1.4004

O
O

N

O
O

g, 0.010 mol) sequentially. Ethyl 4-bromocrotonate (75%, 2.5921 g, 0.010 mol) was then
added dropwise over 25 min. The resulting suspension was stirred overnight, filtered and
concentrated under reduced pressure. The residue was purified by chromatography
(petroleum ether/acetone 9.5:0.5) to give the yellow oil product (2.3252 g, 73% yield). 1H
NMR (CDCl3, 400 MHz) δ 7.30 (m, 5H), 6.96 (dt, 1H, J=15.6, 6.0 Hz,), 6.02 (d, 1H,
J=15.6 Hz), 4.18 (m, 4H), 3.65 (s, 2H), 3.25 (d, 2H, J=5.6 Hz), 2.87 (t, 2H, J=7.2 Hz),
2.58 (t, 2H, J=7.2 Hz), 1.29 (m, 6H);

13

C NMR (CDCl3, 100 MHz) δ 172.3, 166.2,
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145.8, 138.7, 128.8, 128.4, 127.3, 123.3, 60.5, 60.4, 58.3, 54.4, 49.5, 32.9, 14.2, 14.2.
HR-MS(ESI/APCI) calcd for: C18H26NO4 (MH+): 320.1856, found: 320.1857

Preparation of trans-ethyl 1-benzyl-4-(2-ethoxy-2-oxoethyl)pyrrolidine-3carboxylate (35)
To a 100 ml flame-dried round bottom flask with a magnetic stir
bar

were

added

anhydrous

(E)-ethyl

CO 2Et

4-(benzyl(3-ethoxy-3-

oxopropyl)amino)but-2-enoate (1.5294 g, 4.8 mmol) and dry THF

Bn N

CO 2Et

(15 ml). The flask was then flushed with N2 gas and sealed by a rubber septum which was
fitted with a nitrogen balloon. The stirred mixture was cooled to -78oC in a dry
ice/acetone bath and lithium hexamethyldisilazide (1M in THF, 7.2 ml) was introduced
via syringe. The reaction mixture was allowed to warm to room temperature and stirred
for 25 min. The reaction was then quenched by H2O (50 ml) and THF was evaporated
under reduced pressure. The resulting aqueous solution was extracted by EtOAc (3x100
ml). The combined organic extracts were dried by Na2SO4, filtered and concentrated in
vacuo to afford the brown oil product (1.2026 g, 79% yield) without a further
purification. 1H NMR (CDCl3, 600 MHz) δ 7.38(m, 5H), 4.21(m, 4H), 3.76 (s, 2H), 3.26
(q, 1H, J=7.8 Hz), 3.14 (m, 2H), 3.02 (m, 1H), 2.83 (t, 1H, J=8.6 Hz), 2.57 (dd, 1H, J =
6.7, 16.3 Hz), 2.46(dd, 1H, J =16.3, 8.7 Hz), 2.32(t, 1H, J =8.9 Hz), 1.33(m, 6H).

13

C

NMR (CDCl3, 100 MHz), δ173.4, 172.0,132.4, 128.9, 128.4, 127.3, 60.6, 60.5, 60.0,
59.0,55.9,45.2, 36.8, 34.6, 14.2, 14.1. HR-MS(ESI/APCI) calcd for: C18H26NO4 (MH+):
320.1856, found: 320.1854
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If the reaction time is too long, which will lead to the formation of impurities,
chromatography (Hexane/EtOAc 3:1 and then pure EtOAc) can be employed to afford
the desired product.

Preparation of trans-4-(carboxymethyl)pyrrolidine-3-carboxylic acid (27)
A 25ml round bottom flask was charged with trans-ethyl 1-benzyl-4(2-ethoxy-2-oxoethyl)pyrrolidine-3-carboxylate

(0.2061

g,

0.65

CO2 H
HN

CO2 H

mmol) and 10ml 1N HCl solution. The mixture was stirred under reflux for overnight.
The resulting solution was washed by Et2O (2x20 ml) and was evaporated under reduced
pressure to give 0.1811 g crystals. Those crystals was dissolved in 5 ml H2O and
transferred into a Pyrex 9800 test tube, followed by the addition of 2 spatulas of 10%
palladium on activated carbon. The test tube was placed into a PARR reaction bottle (500
ml) which was shaken under H2 (48 psi) in a pressure reaction apparatus for 26 h at room
temperature. The reaction suspension was filtered over a pad of celite and showed a red
spot on TLC by ninhydrin. The filtrate was concentrated in vacuo to give yellow crystals
(0.1019 g, 75% overall yield). 1H NMR (D2O, 400 MHz) δ 3.55-3.65(m, 2H), 3.40(dd,
1H, J =12.4, 6.8 Hz), 3.30(dt, 1H, J =6.9, 2.9 Hz), 3.06(t, 1H, J =10.8 Hz), 2.95(m, 1H),
2.54(d, 2H, J =7.5 Hz). 13C NMR (D2O, 100 MHz), δ175.4, 175.2, 48.4, 47.6, 45.5,36.6,
33.1. HR-MS(ESI/APCI) calcd for: C7H12NO4 (MH+): 174.0761, found: 174.0760
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Preparation of glycine ethyl ester hydrochloride (40)
Glycine (2.1103 g, 28.1 mmol), ethanol (60 ml) and thionyl chloride

O

(2.5 ml, 34.4 mmol) were mixed and stirred at -20oC for 20 min. The H2N

O

HCl

reaction mixture was then warmed to room temperature and a second portion of glycine
(1.9969 g, 26.6 mmol) was added. After stirring for 1 hour, the reaction mixture was
refluxed for 2 more hours before being cooled to room temperature. Ethyl ether was
added to precipitate the product out and after the vacuum filtration, the final product was
obtained as white solid (4.4675 g, 93%). 1H NMR (D2O, 400 MHz) δ 4.24(q, 2H, J=6.8
Hz), 3.84(s, 2H), 1.22(t, 3H, J=6.8 Hz);

13

C NMR (D2O, 100 MHz) δ 168.3, 63.5, 40.3,

13.3 [Cheng, C. et al. 2009].

Preparation of ethyl 2-(benzylamino)acetate (41)
To a 100 ml round bottom flask were added glycine ethyl ester
hydrochloride (2.0980 g, 0.015 mol), tert-butylmethyl ether
(TBME, 30 ml), anhydrous sodium sulfate (2.0469 g, 0.014 mol),

O
O
HN

and distilled benzaldehyde (1.5604 g, 0.015 mol) sequentially. The stirred suspension
was cooled to 0oC in an ice bath and triethylamine (2.928 g, 0.023 mol) was added
dropwise over 10 min. The reaction suspension was then allowed to warm to room
temperature and stirred for 24 hours. After the filtration and evaporation, the yellow oil
was dissolved in 50 ml EtOH. The mixture was cooled to 0oC in an ice bath and sodium
borohydride (1.1583 g, 0.03 mol) was introduced in three portions over 10 min. The
reaction mixture was stirred at room temperature for further 35 min and was quenched by
slowly adding saturated NaHCO3 solution (50 ml). After filtration, the resulting solution
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was extracted by ethyl acetate (3x50 ml). The combined organic extracts were dried by
Na2SO4, filtered and concentrated in vacuo. The residue was purified by chromatography
(petroleum ether/EtOAc 3:2) to give the yellow oil product (2.3112 g, 81% yield). 1H
NMR was consistent with literature [Yoon, U. C. et al. 1992] 1H NMR (CDCl3, 400
MHz) δ 7.30(m, 5H), 4.20 (q, 2H, J =7.2 Hz), 3.80(s, 2H), 3.40(s, 2H), 1.28 (t, 3H, J =7.2
Hz)

Preparation of ethyl 2-(benzyl(but-3-enyl)amino)acetate (39)
A 100 ml round bottom flask was charged with ethyl 2O

(benzylamino)acetate (1.0842 g, 5.62 mmol), acetonitrile (25
N

ml) and K2CO3 (2.4304 g, 17.61 mmol). 4-bromobut-1-ene

O

(2.2929 g, 17.0 mmol) was added dropwise at room temperature. The mixture was stirred
under reflux for 24h and was then filtered, concentrated under reduced pressure. After
purification by chromatography (Hexane/EtOAc 4:1), the yellow oil alkene product
(0.8916 g, 64%) was given. 1H NMR (CDCl3, 400 MHz) δ 7.35(m, 5H), 5.83(m, 1H),
5.05(m, 2H), 4.18(q, 2H, J=7.2 Hz), 3.83(s, 2H), 3.35(s, 2H), 2.76(t, 2H, J=7.2 Hz),
2.30(m, 2H), 1.29(t, 3H, J=7.2 Hz). 13C NMR (CDCl3, 100 MHz), δ171.5, 139.1, 136.6,
128.9, 128.2, 127.0, 115.6, 60.2, 58.1, 54.2, 53.4, 32.2, 14.3. HR-MS(ESI/APCI) calcd
for: C15H22NO2 (MH+): 248.1645, found: 248.1650
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Preparation of cis-ethyl 1-benzyl-3-(cyanomethyl)pyrrolidine-2-carboxylate (42)
To a 25 ml flame-dried round bottom flask were added anhydrous ethyl 2-(benzyl(but-3enyl)amino)acetate (0.3406 g, 1.38mmol) and 2ml dry THF. The flask was then flushed
with N2 gas and sealed by a rubber septum which was fitted with a nitrogen balloon. The
stirred mixture was cooled to -78oC and LDA (1.5 M in
cyclohexane, 1.1 ml) was added dropwise. The reaction

N
N

CO2 Et

temperature was increased to -20oC and then cooled to -100oC at
which Zinc Bromide (1 M in Et2O, 3.4 ml) was introduced dropwise. The reaction
mixture was allowed to warm to room temperature and stirred for 2 hours. CuCN/2LiCl
(1.35 M in THF, 1.4 ml) was added at 0oC, followed by the addition of tosylcyanide
(0.3001 g, 1.66 mmol) after 10 min. The reaction suspension was allowed to warm to
room temperature and stirred for overnight. This reaction was then quenched by saturated
NH4Cl (30 ml). The resulting solution was extracted by Et2O (30 ml) and CH2Cl2 (2x30
ml). The combined organic extracts were dried by Na2SO4, filtered and concentrated in
vacuo. After chromatography (Hexane/EtOAc 9:1), the yellow oil product (0.1220g,
33%) was obtained. 1H NMR (CDCl3, 400 MHz) δ 7.20 (m, 5H), 4.11(q, 2H, J=7.2 Hz),
3.49-3.82(AB, 2H), 3.40(d, 1H, J=7.6 Hz), 3.05(m, 1H), 2.69(m, 1H), 2.51(m, 1H), 2.402.29(m, 2H), 2.11(m, 1H), 1.68(m, 1H), 1.21(t, 3H, J=7.2 Hz).

13

C NMR (CDCl3, 100

MHz), δ171.3, 138.0, 129.0, 128.3, 127.3, 118.4, 67.4, 60.9, 57.5, 51.3, 37.9, 29.7, 19.6,
14.3. HR-MS(ESI/APCI) calcd for: C16H21N2O2 (MH+): 273.1598, found: 273.1593
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Preparation of cis-3-carboxymethyl-pyrrolidine-2-carboxylic acid (cis-CPAA) (43)
A 25 ml round bottom flask was charged with cis-ethyl 1-benzyl-3(cyanomethyl)pyrrolidine-2-carboxylate (0.1220 g, 0.45 mmol) and 7

CO 2H
N
H

CO 2H

ml 6N HCl solution. The mixture was stirred under reflux for overnight. The resulting
solution was concentrated under reduced pressure to give yellow crystals. Those crystals
was dissolved in 5 ml H2O and transferred into a Pyrex 9800 test tube, followed by the
addition of 1 spatulas of 10% palladium on activated carbon. The test tube was placed
into a PARR reaction bottle (500 ml) which was shaken under H2 (50 psi) in a pressure
reaction apparatus for 24h at room temperature. The reaction suspension was filtered
over a pad of Celite and the filtrate was concentrated in vacuo to give yellow crystals
(0.1252 g). After purification by ion-exchange chromatography (Dowex 50-X8, washed
by water and then 1M NH4Cl), the desired compound was obtained as a colorless crystals
(0.0414 g, 45%). The structure was confirmed by comparison of their spectral data with
those reported in the literature. [Karoyan, P. and Chassaing, G. 2002] 1H NMR (D2O,
400 MHz) δ 4.09 (d, 1H, J=8.0 Hz), 3.47(m, 1H), 3.24(m, 1H), 2.83(m, 1H), 2.37(dd, 1H,
J= 15.6, 4.8 Hz), 2.13(m, 2H), 1.74(m, 1H).

Preparation of trans-3-carboxymethyl-pyrrolidine-2-carboxylic acid (trans-CPAA)
(38)
Cis-3-carboxymethyl-pyrrolidine-2-carboxylic acid (0.1142 g, 0.55
mmol) was acidified by 1N HCl, dissolved into 3 ml H2O and

CO 2H
N
H

CO 2H

transferred into a pressure tube. The mixture was heated at 190oC for 12h to give a
mixture of cis/trans 20:80 as seen when comparing the intensities of the doublet peak at
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4.32 ppm (the α hydrogen of the cis isomer) to the doublet peak at 3.99 ppm (the α
hydrogen of the trans isomer). Upon evaporation, the crystals were dissolved in 8 ml
H2O, cooled to 0oC at which Na2CO3 (0.1998 g, 1.88 mmol) and benzyl chloromate
(0.1116 g, 0.66 mmol) in 2 ml 1, 3-dioxane were added. The reaction solution was then
allowed to warm to room temperature and stirred for 21 hours. 15 ml H2O was added and
the resulting solution was washed by Et2O (2x20 ml). The aqueous layer was acidified by
1N HCl solution until its pH<2. The resulting aqueous solution was extracted by EtOAc
(4x30 ml). The combined organic extracts were dried by Na2SO4, filtered and
concentrated in vacuo to give an intermediate product. This intermediate was dissolved in
3 ml CH2Cl2, cooled to 0oC at which 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide
hydrochloride (0.2524 g, 1.31 mmol), 4-Dimethylaminopyridine (0.0532 g, 0.44 mmol)
and 1 ml EtOH were added. The reaction solution was then allowed to warm to room
temperature and stirred for 20 hours. After the removal of solvents, chromatography
(hexane/EtOAc 3:1) was used to obtain a mixture of trans/cis Cbz protected CPAA
derivative (0.0855 g, 43%).

Preparative HPLC (methanol/H2O 65:35, flow rate: 8 ml/min) was employed to afford
the pure trans Cbz protected CPAA derivative (retention time: 52 min, 0.028 g, 0.077
mmol). This trans derivative was dissolved in 3 ml Methanol, treated with a spatula of
10% palladium on activated carbon and went through hydrogenolysis under H2 (50 psi)
for 24 h at room temperature. After filtration and evaporation, the hydrolysis of the
residue was carried on in refluxing 4N HCl overnight to give the desired product (0.0128
g, 79%). The structure was confirmed by comparison of their spectral data with those
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reported in the literature. [Karoyan, P. and Chassaing, G. 2002][Oba, M. et al. 2009] 1H
NMR (D2O, 400 MHz) δ 3.99(d, 1H, J=8.0 Hz), 3.41(m, 2H), 2.70-2.85(m, 2H), 2.55(m,
1H), 2.29(m, 1H), 1.78(m, 1H).

13

C NMR (D2O, 100 MHz), δ175.5, 171.4, 63.3, 45.2,

38.6, 36.3, 29.8.

Preparation of N-benzylidene-benzylamine N-oxide (44)
To a 250 ml two-necked flask equipped with a magnetic stir bar,
thermometer and a reflux condenser fitted with a rubber septum

N
O

and a balloon of nitrogen were added a solution of methyltrioxorhenium (MTO) (10 mg,
0.04 mmol) in 15 ml methanol and urea hydrogen peroxide (UHP) (1.4650 g, 15.6
mmol). The flask was cooled in an ice bath and dibenzylamine (1 ml, 5.21 mmol) was
added dropwise via syringe over 10 min. The ice bath was then removed and the reaction
mixture was stirred at room temperature. After 20 min, another four portions of MTO (14
mg each in 5 ml methanol) were added at 30 min intervals. 30 min after the last addition,
the flask was cooled in an ice bath and sodium thiosulfate pentahydrate (1.3318 g, 5.37
mmol) was added in portions over 20 min. One hour later, the solution was decanted into
a 250 ml flask and the solvent was evaporated under reduced pressure. CH2Cl2 (50 ml)
was added and the urea was filtered through a pad of celite. The filtrate was concentrated
to afford the nitrone (0.8732 g, 79% yield) as a yellow solid. If desired, a recrystallization
can be performed in diethyl ether to provide the nitrone as a white solid. M.P. 77-78oC.
1

H NMR (CDCl3, 400 MHz) δ8.17-8.20 (m, 2H), 7.38-7.49 (m, 9H), 5.09 (s, 2H);

13

C

NMR (CDCl3, 100 MHz), δ134.1, 133.4, 130.5, 130.4, 129.2, 128.9, 128.6, 128.4, 71.3
[Goti, A. et al. 2005].
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Preparation of titanium dichlorodiisoproxide (2M in CH2Cl2) To a 25 ml flame-dried
round bottom flask fitted with a rubber septum and a balloon of nitrogen were added dry
CH2Cl2 (10 ml), Ti(i-OPr)2 (6.1 ml) and TiCl2 (2.2 ml) via syringes under an ice bath.
The stirred mixture was then warm to room temperature and stirred for one hour. The
solution was stored under nitrogen in a freezer (-20oC).

Preparation of MgI2-Phenanthroline (0.1M in CH2Cl2) [Gothelf, K. V. et al. 1996]
Magnesium (103.5 g, 4.6 mmol), I2(448.6 mg,1.8 mmol) and diethyl ether (10 ml) were
placed in a 25 ml flask with a magnetic stirring bar under N2. The mixture was stirred at
room temperature 3h in which the iodine color disappeared. A syringe was employed to
transfer the clear solution into a 100ml flame-dried flask. The ethyl ether was evaporated
to form white MgI2. Immediately, dry CH2Cl2 (40 ml) and phenanthroline (450 mg in 10
ml dry CH2Cl2, 2.5 mmol) was added. After the milky suspension was stirred for 2 hours,
I2(430.5 mg,1.7 mmol) was added. The deep red suspension was stirred for another 2
hours before use.

Preparation of (E)-3-but-2-enoyloxazolidin-2-one (47)
To a 100 ml flame-dried round bottom flask with a magnetic stir bar
were added anhydrous 2-oxazolidinone (1.7461 g, 0.02 mol) and dry

O

O
N

O

THF (20 ml). The flask was then flushed with N2 gas and sealed by a rubber septum
which was fitted with a nitrogen balloon. The stirred mixture was cooled to -78oC in a
dry ice/acetone bath and n-butyl lithium (1.6M in hexane, 12.5 ml) was introduced via
syringe. After stirring for 1 hour, crotonoyl chloride (90%, 2.2 ml, 0.021 mol) was added
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through syringe and the reaction solution was slowly warmed to room temperature. After
stirring for further 3 hours, the reaction was quenched by adding saturated NH4Cl
solution (60 ml). The mixture was extracted by EtOAc (3x50 ml). The combined organic
extracts were dried by Na2SO4, filtered and concentrated in vacuo. The residue was
purified by chromatography (1:1 hexane/EtOAc) to give the white solid product (1.7194
g, 55% yield). 1H NMR (CDCl3, 400 MHz) δ 7.26-7.18(m, 2H), 4.42(t, 2H, J=8.0 Hz),
4.03(t, 2H, J=8.0 Hz), 1.92(d, 3H, J=6.4 Hz);

13

C NMR (CDCl3, 100 MHz) δ 195.9,

165.2, 146.8, 121.4, 62.0, 42.6, 18.5 [Nakamura, T. et al. 2007].

Preparation of 3-(2-benzyl-5-methyl-3-phenylisoxazolidine-4-carbonyl)oxazolidin-2one
A 25 ml flame-dried flask were charged with N-benzylidenebenzylamine N-oxide (107.2 mg, 0.51 mmol), (E)-3-but-2enoyloxazolidin-2-one (62.8 mg, 0.41 mmol), powered 4A
molecular sieve (54.1 mg) and dry CH2Cl2 (3 ml). The flask was

N O

Ph
Ph

O

N
O
O

then flushed with N2 gas and sealed by a rubber septum which was fitted with a nitrogen
balloon. TiCl2(i-OPr)2 (2M in CH2Cl2, 0.05 ml) was added via syringe. The resulting
suspension was stirred at room temperature for 4 days. A mixture of 5% methanol and
95% CH2Cl2 (10 ml) was added and the cloudy solution was then filtered. After the
evaporation in vacuo, the crude product was purified by chromatography (3:1
EtO2/petroleum ether) gave a mixture of exo adduct and endo adduct (9:1) (0.0555 g,
37% yield). The exo adduct (major product) was confirmed by comparison of their
spectral data with those reported in the literature. 1H NMR (CDCl3, 400 MHz) δ7.43-
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7.23(m, 10H), 4.94(m, 1H), 4.30-4.42(m, 2H), 4.12(m, 1H), 3.93(d, 1H, J=14.4 Hz),
3.80(d, 1H, J=14.4 Hz), 3.66(m, 2H), 3.08(m, 1H), 1.35(d, 3H, J=6.0 Hz);

13

C NMR

(CDCl3, 100 MHz) δ170.3, 152.9, 137.4, 136.9, 129.0, 128.7, 128.4, 128.2, 127.0, 74.6,
73.4, 61.9, 59.7, 59.6, 42.4, 18.0 [Gothelf, K. V. and Jorgensen, K. A. 1994].

Preparation of (E, E)-Hexa-2, 4-dienoyl chloride (sorbyl chloride) (48)
A 25 ml flask equipped with a CaCl2 dring tube was charged with (E,

O
Cl

E)-hexa-2, 4-dienoic acid (sorbic acid) (2.9445 g, 26.4 mmol), oxalyl

chloride (4 ml, 45.5 mmol), dry CH2Cl2 (40 ml) and 3 drops DMF. The reaction solution
was stirred for 4.5 hours and the solvent was evaporated under reduced pressure. The
crude product was purified via Kugelrohr distillation to afford the yellow oil product
(2.9163 g, 86%). 1H NMR (CDCl3, 400 MHz) δ7.44 (dd, 1H, J=14.8, 10.8 Hz), 6.466.22(m, 2H), 6.00(d, 1H, J=14.8 Hz), 1.94(d, 3H, J=6.0 Hz) [Davies, S. G. et al. 2004].

Preparation of 3-(2E, 4E)-hexa-2,4-dienoyloxazolidin-2-one (49)
A 100 ml flame-dried round bottom flask with a magnetic stir
O

bar was charged with anhydrous 2-oxazolidinone (1.0953 g,

O
N

O

12.6 mmol) and dry THF (10 ml). The flask was then flushed
with N2 gas and sealed by a rubber septum which was fitted with a nitrogen balloon. The
stirred mixture was cooled to -78oC in a dry ice/acetone bath and n-butyl lithium (1.6M in
hexane, 8 ml) was introduced via syringe. After stirring for 3 hour, (E, E)-Hexa-2, 4dienoyl chloride (sorbyl chloride) (2.1713 g, 16.8 mmol) was added through syringe and
the reaction solution was slowly warmed to room temperature. After stirring for further
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2.5 hours, the reaction was quenched by adding saturated NH4Cl solution (30 ml),
followed by adding brine (20 ml). The mixture was extracted by EtOAc (3x50 ml). The
combined organic extracts were washed by water (3x50 ml) and brine (50 ml). The
resulting organic layer was dried by Na2SO4, filtered and concentrated in vacuo to give
the white solid product (1.6995 g, 75%yield). M.P. 123-126oC; 1H NMR (CDCl3, 400
MHz) δ 7.47(dd, 1H, J=15.2, 10.8 Hz), 7.22(d, 1H, J=15.2 Hz), 6.38-6.21(m, 2H), 4.43(t,
2H, J=8.4 Hz), 4.10(t, 2H, J=8.4 Hz), 1.90(d, 3H, J=6.4 Hz);

13

C NMR (CDCl3, 100

MHz) δ 165.7, 153.5, 146.8, 141.1, 130.4, 117.5, 62.0, 42.8, 18.8.

Preparation of N-benzylhydroxylamine hydrochloride (59)
To a 25 ml flask were added benzaldehyde oxime (0.1850 g, 1.53

N
H

OH

mmol), methanol (1 ml) and a little methyl orange. The solution was
cooled to 0oC in an ice bath and methanol-HCl solution (carefully mixed 3:1
methanol/acetyl chloride under an ice bath) was dropwise added to make the solution turn
to pink. NaCNBH3 (0.0747 mg, 1.19 mmol) was added in three portions and methanolHCl solution was used to maintain the pink color of the reaction solution. Upon the
addition of NaCNBH3, the reaction solution was warmed to room temperature and was
stirred for 2 and half hours while staying pink by adding methanol-HCl solution
occasionally. Methanol was evaporated under reduced pressure and 1ml water was added
to the residue. The formed suspension was basified until the pH was higher than 9 using
25% NaOH solution. Brine (20 ml) was added and the solution was extracted by CH2Cl2
(3x25 ml) and the combined organic layers were dried by Na2SO4, filtered and
concentrated in vacuo to offer the yellow solid product (0.1780 g, 95%). 1H NMR
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(CDCl3, 400 MHz) δ7.44-7.28(m, 5H), 6.13(s, 2H, exch D2O), 3.99 (s, 2H) [Maskill, H.
and Jencks, W. P. 1987].
Preparation of tetrahydro-2H-pyran-2-ol (60)
2, 3-dihydropyran (4.3376 g, 51.6 mmol) was mixed with 2N HCl solution (10
ml) at 0 °C, stirred for 40 min and then stirred at room temperature for 1 h. The

OH
O

reaction solution was neutralized by saturated NaHCO3 solution. The resultant
mixture was extracted with CH2Cl2 (2x60 ml). The combined organic layer was dried by
NaSO4, filtered and concentrated in vacuo to afford a crude prodeuct. After a vacuum
distillation, the desired product was collected as colorless oil (3.9508 g, 75%). 1H NMR
(CDCl3, 400 MHz) δ4.92(m, 1H), 4.02(m, 1H), 3.52 (m, 1H), 1.83(m, 2H), 1.51(m, 4H)
[Murphy, P. J. et al. 1996].

Preparation of (3aR, 6aR)-2,2-dimethyl-tetrahydrofuro[3,4-d][1,3]dioxol-4-ol (64)
To a 100ml flask were added D-Ribose (1.9499 g, 13.0 mmol), anhydrous
acetone (10 ml) and concentrated sulfuric acid (0.1 ml). The suspension
was stirred at room temperature and after 30min the cloudy suspension O

O
OH
O

graduately became clear. After stirring for further 1 hour, 10 ml acetone
was added and Ca(OH)2 was employed to adjust the pH to 7. The resulting suspension
was filtered through a pad of celite and evaporated to give the yellow oil product (2.4769
g, 100%) as (3aR, 6R, 6aR)-6-(hydroxymethyl)-2, 2-dimethyl-tetrahydrofuro[3,4d][1,3]dioxol-4-ol

which can be used directly in next step without the need of

purification.
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(3aR, 6R, 6aR)-6-(hydroxymethyl)-2, 2-dimethyl-tetrahydrofuro[3,4-d][1,3]dioxol-4-ol
(3.2071 g, 16.9 mmol) was dissolved in methanol (75 ml). The solution was cooled to
0oC in an ice bath and NaBH4 (2.7 g, 71.1 mmol) was added in 3 portions over 30 min.
The solution was stirred for 2 more hours at 0oC and was then neutralized by glacial
acetic acid. After the ice bath was removed, water (50 ml) and NaIO4 (6.7374 g, 31.5
mmol) was added sequentially. The mixture was stirred for 3 hours and was filtered and
concentrated to remove the methanol under reduced pressure. The residue was extracted
by EtOAc (3x40 ml). The combined extracts were washed by brine (100 ml) and dried by
Na2SO4, filtered and concentrated in vacuo. The residue was purified by a short pad of
silica gel, eluated by 1:1 hexane/EtOAc mixture to give the colorless oil product (1.7503
g, 69%). 1H NMR (CDCl3, 400 MHz) δ5.45(s, 1H), 4.86(m, 1H), 4.61(d, 1H, J=5.6 Hz),
4.08(m, 2H), 1.50(s, 3H), 1.35(s, 3H) [Hudlicky, T. et al. 1990].

Preparation of (3aR, 4R, 6aR)-N-Benzyl-tetrahydro-N-hydroxy-2,2-dimethylfuro[3,4-d]-1,3-dioxol-4-amine (65)
N-benzylhydroxylamine hydrochloride (0.1236 g, 1.0 mmol), (3aR,
6aR)-2,2-dimethyl-tetrahydrofuro[3,4-d][1,3]dioxol-4-ol (0.1407 g,
0.88 mmol), 3A molecular sieve (33.6 mg) and dry pyridine (2 ml)

Ph
O
O

N OH
O

were mixed together in a 10 ml flask fitted with a CaCl2 drying tube and stirred
overnight. The mixture was then diluted by adding 2 ml CH2Cl2, filtered through a pad of
celite and concentrated under reduced pressure. The residue was purified by a short pad
of silica gel, eluated by 3:1 Petroleum ether/EtOAc solvent mixture to give a light yellow
solid product (0.2154 g, 92%). 1H NMR (CDCl3, 400 MHz) δ7.34(m, 5H), 4.93(d, 1H,
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J= 6.0Hz), 4.89(dd, 1H, J=6.0, 4.4 Hz), 4.74(s, 1H), 4.28(dd, 1H, J=9.6, 4.4 Hz), 4.10(m,
2H), 3.89(d, 1H, J= 13.2Hz), 1.52(s, 3H), 1.36(s, 3H);

13

C NMR (CDCl3, 100 MHz)

δ137.0, 129.5, 128.5, 127.5, 112.1, 99.7, 83.9, 81.1, 76.4, 59.4, 26.5, 24.8 [Cicchi, S. et
al. 2003].

Preparation of (3aR, 4R, 6aR)-Tetrahydro-2,2-dimethyl-N-(phenylmethylene)furo[3,4-d][1,3]dioxol-4-amine N-Oxide (53)
(3aR,

4R,

6aR)-N-Benzyl-tetrahydro-N-hydroxy-2,2-dimethylfuro-

[3,4-d]-1,3-dioxol-4-amine (0.1907 g, 0.71 mmol) was dissolved in

Ph
O
O

N O
O

o

CH2Cl2 (3 ml). The solution was cooled to 0 C under an ice bath and
MnO2 (85%, 0.1109 g, 1.08 mmol) was added. The suspension was warmed to room
temperature and stirred overnight. The suspension was then filtered through one layer of
celite (top) and one layer of Na2SO4 (bottom), followed by CH2Cl2 washing those two
layers. The solvent was evaporated in vacuo to give the solid product (0.1533 g, 81%).
1

H NMR (CDCl3, 400 MHz) δ 8.26(m, 2H), 7.63(s, 1H), 7.45(m, 3H), 5.53(s, 1H),

5.35(d, 1H, J=6.0 Hz), 5.03(dd, 1H, J=6.0, 4.0 Hz), 4.53(dd, 1H, J=10.0 ,4.0 Hz), 4.32(d,
1H, J=10.0 Hz), 1.55(s, 3H), 1.39(s, 3H);

13

C NMR(CDCl3, 100 MHz) δ 132.8, 131.0,

129.6, 128.9, 128.5, 112.9, 104.0, 84.4, 80.5, 77.2, 26.3, 24.7 [Cicchi, S. et al. 2003].

Preparation of (E)-ethyl 4-acetoxybut-2-enoate (55)
Ethyl 4-bromocrotonate (75%, 0.3889 g, 1.51 mmol), acetic acid (5

O
AcO

ml) and silver acetate (0.2848 g, 1.71 mmol) were mixed together

OEt

in a 25 ml flask fitted with a condenser and drying tube (CaCl2). The formed suspension
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was stirred at reflux at for 23h. The solution was filtered and washed by EtOAc. The
solvents were evaporated in vacuo and the residue was purified by chromatography (4:1
hexane/EtOAc) to give an oil product (0.2095 g, 81% yield). 1H NMR (CDCl3, 400
MHz) δ 6.96(dt, 1H, J=15.6, 4.4 Hz), 6.04(d, 1H, J=15.6 Hz), 4.75(dd, 2H, J=4.4, 1.6
Hz), 4.22(q, 2H, J=7.2 Hz), 2.14(s, 3H), 1.31(t, 3H, J=7.2 Hz).

Preparation of (3R, 4S, 5S)-ethyl 5-(acetoxymethyl)-2-((3aR, 4R, 6aR)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)-3-phenylisoxazolidine-4-carboxylate (66)
To a 50 ml flask equipped with a magnetic stir bar and a reflux
condenser were added

(3aR, 4R, 6aR)-Tetrahydro-2,2-

dimethyl-N-(phenylmethylene)furo-[3,4-d][1,3]dioxol-4-

O
N

O
O

O

Ph

OAc

O
O

amine N-Oxide (532.6 mg, 2.03 mmol), (E)-ethyl 4acetoxybut-2-enoate (175.8 g, 1.02 mmol), powered 4A molecular sieve (100.2 mg) and
Toluene (10 ml). The reaction mixture was refluxed for 6 days and was filtered through a
pad of celite. The solution was concentrated under reduced pressure and the residue was
purified by chromatography (3:1 hexane/EtOAc) to afford the final product (0.1965 g,
44%).

1

H NMR (CDCl3, 400 MHz) δ 7.44-7.24(m, 5H), 4.99(d, 1H, J=6.0 Hz), 4.83-

4.76(m, 3H), 4.73(m, 1H), 4.35(dd, 1H, J=12.0, 3.6 Hz), 4.29-4.20(m, 3H), 3.88(t, 1H,
J=10.4 Hz), 3.77(dd, 1H, J=10.4, 4.0 Hz), 3.30(dd, 1H, J=7.2, 6.4 Hz), 1.98(s, 3H),
1.49(s, 3H), 1.35(s, 3H), 1.29(t, 3H, J=6.8 Hz);

13

C NMR (CDCl3, 100 MHz) δ 170.9,

170.6, 140.5, 128.6, 127.6, 126.8, 112.2, 97.8, 83.2, 80.6, 79.1, 73.9, 68.7, 63.2, 61.7,
59.2, 26.3, 24.9, 20.6, 14.1. LC MS calcd for: C22H30NO3 (MH+): 436.2, found: 436.4
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Preparation of 3-(2-Propenoyl)-l,3-oxazolidin-2-one (73)
To a 100 ml flask were charged with 20 ml CH2Cl2 and NaH (60%,

O

1.6823 g, 42.1 mmol). The suspension was cooled to 0oC at which 2-

O
N

O

oxazolidinone (1.7824 g, 20.7 mmol) was added, resulting in bubbling. After the
bubbling stops, the suspension was cooled to -78oC and propenoyl chloride (1.46 ml, 18.1
mmol) was introduced. The reaction solution was then warmed to room temperature and
stirred for 23 hours. The reaction solution was filtered through a short pad of silica gel,
eluted by CH2Cl2. The resulting solution was evaporated under reduced pressure at 30oC
to form 3-(2-Propenoyl)-l,3-oxazolidin-2-one as white solid (1.0163 g, 40% yield). 1H
NMR (CDCl3, 400 MHz) δ7.45(m, 1H), 6.50(dd, 1H, J=16.8, 1.6 Hz), 5.84(dd, 1H,
J=10.4, 1.6 Hz), 4.38(t, 2H, J=8.4 Hz), 4.02(t, 2H, J=8.4 Hz) [Narasaka, K. et al. 1989]

Preparation of 3-cinnamoyloxazolidin-2-one (78)
Oxazolidinone (0.8704 g, 10.0mmol), DMAP (0.2524 g, 2.1
mmol) and cinamic acid (1.9293 g, 13.0 mmol) was mixed in 20

O

O
N

O

ml CH2Cl2 in a 100 ml flask. The suspension was then cooled to 0oC and DCC (2.6701 g,
10.0 mmol) was added. After 10 min, the temperature was raised to room temperature
and the reaction solution was stirred for 4 hours. The precipitate was fitered out and
washed by CH2Cl2. The filtrate was washed by saturated NaHCO3 (50 ml), dried by
Na2SO4 and concentrated in vacuo. The residue was purified by radial chromatography
(3:1 hexane/EtOAc) to afford the desired product (2.0449 g, 95%). 1H NMR (CDCl3, 400
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MHz) δ7.82(m, 2H), 7.55(m, 2H), 7.35(m, 3H), 4.40(t, 2H, J=8.0 Hz), 4.10(t, 2H, J=8.0
Hz) [Sibi, M. P. and Manyem, S. 2002].

Preparation of (E)-3-(4-bromobut-2-enoyl)oxazolidin-2-one (57)
Crotonic acid (0.2752 g, 3.2 mmol) was dissolved in CCl4 (8 ml),

O
Br

followed by adding NBS (0.5981 g, 3.4 mmol) and benzoyl

O
N

O

peroxide (75%, 0.0211 g, 0.1 mmol). The resulting suspension was refluxed under N2
atmosphere overnight and cooled to room temperature. After filtration, thionyl chloride
(0.4 ml, 4.5 mmol) was added to the solution and the mixture was stirred at 60oC in a
round bottom flask equipped with a condenser and drying tube (CaCl2) overnight. The
solution was concentrated in vacuo to give crude (E)-4-bromobut-2-enoyl chloride which
was dissolved in dry THF (3 ml). The flask of this solution was then flushed by N2 flow
and sealed by a rubber septum.

To a 100 ml flame-dried round bottom flask with a magnetic stir bar were added
anhydrous 2-oxazolidone (0.2500 g, 2.9 mmol) and dry THF (4 ml). The flask was then
flushed with N2 gas and sealed by a rubber septum which was fitted with a nitrogen
balloon. The stirred mixture was cooled to -78oC in a dry ice/acetone bath and nbutyllithium (1.6M in hexane, 1.8 ml, 2.9 mmol) was introduced via syringe. After one
hour, more dry ice was added to the dry ice/acetone bath and the activated 2-oxazolidone
was added dropwise via a cannula to the flask containing (E)-4-bromobut-2-enoyl
chloride which was also cooled to -78oC. After the addition, the reaction mixture was
allowed to warm to room temperature and stirred for 3 hours. The reaction was then

113

quenched by H2O (10 ml) and brine (20 ml). The mixture was extracted by EtOAc (3x35
ml). The combined organic extracts were dried by Na2SO4, filtered and concentrated in
vacuo. The residue was purified by chromatography (9:1 hexane/EtOAc then 7:3
hexane/EtOAc) to give the light yellow oil product (0.3404 g, 51% yield). 1H NMR
(CDCl3, 400 MHz) δ 7.48(d, 1H, J=15.2 Hz), 7.18(dt, 1H, J=15.2, 7.6 Hz), 4.45(t, 2H,
J=7.6 Hz), 4.09(m, 4H); 13C NMR (CDCl3, 100 MHz) δ164.1, 153.3, 143.3, 122.8, 62.2,
42.6, 29.3. HR-MS(ESI/APCI) calcd for: C7H9NO3Br(MH+): 233.9760, found:
233.9768

Preparation of (S, E)-3-(4-bromobut-2-enoyl)-4-isopropyloxazolidin-2-one (94)
This compound was prepared in the similar way of preparing (E)3-(4-bromobut-2-enoyl)oxazolidin-2-one.

Crotonic

acid

was

O
Br

O
N

O

treated with NBS and thionyl chloride sequentially to give (E)-4bromobut-2-enoyl chloride which reacted with (S)-4-isopropyloxazolidin-2-one in the
presence of n-butyllithium. 34% yield.

1

H NMR (CDCl3, 400 MHz) δ7.50(dt, 1H,

J=14.8, 1.2 Hz), 7.17(dt, 1H, J=14.8, 7.6 Hz), 4.52(m, 1H), 4.27(m, 2H), 4.10(dt, 2H,
J=7.6, 1.2 Hz), 2.45(m, 1H), 0.96(d, 3H, J=7.2 Hz), 0.91(d, 3H, J=6.8 Hz).

13

C NMR

(CDCl3, 100 MHz) δ164.0, 153.9, 143.1, 123.3, 63.5, 58.6, 29.4, 28.4, 18.0, 15.0. HRMS(ESI/APCI) calcd for: C10H15NO3Br (MH+): 276.0230, found: 276.0222

Preparation of (E)-4-oxo-4-(2-oxooxazolidin-3-yl)but-2-enyl
acetate (58)
(E)-3-(4-bromobut-2-enoyl)oxazolidin-2-one (0.1121 g, 0.48

O
AcO

O
N

O

mmol) was dissolved in acetic acid (5 ml), followed by adding silver acetate (0.0888 g,

114

0.53 mmol). The formed suspension was stirred at 100oC under a drying tube (CaCl2) for
22h. The solution was filtered and water (25 ml) was added to the filtrate, followed by
extraction by EtOAc (3x25 ml). The combined organic layers were washed by saturated
NaHCO3 solution until all of the acetic acid was removed. The solution was then dried by
Na2SO4, filtered and concentrated in vacuo. The residue was purified by chromatography
(3:1:1 hexane/EtOAc/CH2Cl2) to give a yellow oil product (0.0476 g, 47% yield). 1H
NMR (CDCl3, 400 MHz) δ7.45(d, 1H, J=15.6 Hz), 7.12(dt, 1H, J=15.6, 4.4 Hz), 4.81(d,
2H, J=4.4 Hz), 4.45(t, 2H, J=8.0 Hz), 4.09(t, 2H, J=8.0 Hz), 2.15(s, 3H);

13

C NMR

(CDCl3, 100 MHz), δ170.4, 164.4, 153.4, 143.0, 120.6, 62.9, 62.1, 42.6, 20.7. HRMS(ESI/APCI) calcd for: C9H12NO5 (MH+): 214.0710, found: 214.0714

Preparation of (S, E)-4-(4-isopropyl-2-oxooxazolidin-3-yl)-4-oxobut-2-enyl acetate
(92)
This compound was prepared in the similar way of preparing AcO
(E)-4-oxo-4-(2-oxooxazolidin-3-yl)but-2-enyl acetate. (S, E)-3-

O

O
N

O

(4-bromobut-2-enoyl)-4-isopropyloxazolidin-2-one was stirred
with silver acetate in reflux acetic acid for 24h. 61% yield. 1H NMR (CDCl3, 400 MHz)
δ7.41(dt, 1H, J=15.6, 2.0 Hz), 7.02(dt, 1H, J=15.6, 4.8 Hz), 4.75(dd, 2H, J=4.8, 2.0 Hz),
4.43(m, 1H), 4.23(dd, 1H, J=9.2, 8.4 Hz), 4.16(dd, 1H, J=9.2, 3.2 Hz), 2.34(m, 1H),
2.08(s, 3H), 0.87(d, 3H, J=6.8 Hz), 0.82(d, 3H, J=7.2 Hz);

13

C NMR (CDCl3, 100

MHz), δ170.3, 164.2, 153.9, 142.8, 121.1, 63.5, 62.9, 58.6, 28.5, 20.7, 18.0, 14.7. HRMS(ESI/APCI) calcd for: C12H18NO5 (MH+): 256.1179, found: 256.1176
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Preparation of benzophenone oxime (71)
To a 250 ml flask with a magnetic stir bar were added benzophenone

N

OH

(5.5012 g, 30.2 mmol), hydroxylamine hydrochloride (7.6079 g, 109.4
mmol), methanol (100 ml) and pyridine (12 ml). The mixture was
stirred at room temperature overnight. The solvents were evaporated in vacuo and a
mixture of hexane (35 ml) and EtOAc (35 ml) was added to the residue. The liquid part
was decanted into a separatory funnel, washed by 1N HCl solution (50 ml), water (50 ml)
and brine (50 ml) sequentially. The solution was dried by Na2SO4, filtered and
concentrated in vacuo to give the desired product as white solid (5.2307 g, 88%). 1H
NMR (400 MHz, CDCl3) δ7.87(s, br, 1H), 7.54-7.33(m, 10H);

13

C NMR (100 MHz,

CDCl3) δ157.8, 136.1, 132.6, 129.5, 129.2, 129.1, 128.3, 128.2, 127.8 [Liu, S. et al.
2007].

Preparation of N-diphenylmethylhydroxylamine (72)
Benzophenone oxime (5.2307 g, 26.4 mmol) was dissolved in

HO

NH

methanol (50 ml) in a flask. After a little methyl orange was added,
the solution was cooled to 0oC in an ice bath and 6N HCl solution
was dropwise added to make the solution turn to pink. NaCNBH3(4.5228 g, 71.8 mmol)
in methanol (10 ml) was then dropwise added into the solution and 6N HCl was used to
maintain the pink color of the reaction solution. Upon the addition of NaCNBH3, the
reaction solution was warmed to room temperature and was stirred for 4 hours while
staying pink by adding 6N HCl occasionally. Saturated NaHCO3 solution was employed
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to basify the solution, after which methanol was evaporated under reduced pressure. The
residue was extracted by CH2Cl2 (3x100 ml) and the combined organic layers were dried
by Na2SO4, filtered and concentrated in vacuo to offer the yellow oil product (5.2471 g,
99%). 1H NMR (400 MHz, CDCl3) δ7.45-7.26(m, 10H), 5.26(s, 1H);

13

C NMR (100

MHz, CDCl3) δ140.5, 128.8, 127.9, 127.8, 70.7 [Sivappa, R. et al. 2007].

Preparation of (Z)-N-Benzylidenediphenylmethylamine N-Oxide (67)
The method described by Hashimoto et al. was followed with some
modification.

To

an

100ml

flask

were

added

N-

diphenylmethylhydroxylamine(4.4160 g, 22.01 mmol), benzaldehyde(3.5205

Ph

O
N

Ph
Ph

g, 33.21 mmol) and CH2Cl2(15 ml). The mixture was stirred at room temperature for 4h.
The solvent was evaporated in vacuo and cool ethyl ether was added to the residue. The
vacuum filtration afforded the nitrone as white solid (5.1370 g, 81%). 1H NMR (400
MHz, CDCl3) δ8.29-8.24 (m, 2H), 7.51 (s, 1H), 7.46-7.30 (m, 13H), 6.40 (s, 1H);

13

C

NMR (100 MHz, CDCl3) δ137.1, 134.9, 130.5, 130.4, 128.8, 128.76, 128.75, 128.6,
128.5, 83.8 [Hashimoto, T. et al. 2007].

Preparation of 3-(2-benzhydryl-5-methyl-3-phenylisoxazolidine-4carbonyl)oxazolidin-2-one (exo adduct) (74)
To a 100 ml flame-dried flask were added N-benzylidene-

Ph

benzhydrylamine N-oxide (1.0627 g, 3.7 mmol), (E)-3-but-2- Ph
enoyloxazolidin-2-one (0.6780 g, 4.4 mmol), powered 4A

N

O

Ph
O

N
O
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O

molecular sieve (1.0121 g) and dry CH2Cl2 (12 ml). The flask was then flushed with N2
gas and sealed by a rubber septum which was fitted with a nitrogen balloon. TiCl2(iOPr)2 (2M in CH2Cl2, 0.5 ml) was added via syringe. The resulting suspension was
stirred at room temperature for 9 days. A mixture of 20% methanol and 80% CH2Cl2 (25
ml) was added and the cloudy solution was then filtered through one layer of celite (top)
and one layer of silica gel (bottom), followed by CH2Cl2 (20 ml) washing those two
layers.

The

solvent

was

evaporated

in vacuo.

The

chromatography

(4:1:1

hexane/EtOAc/CH2Cl2) gave a mixture of exo adduct and endo adduct (8.6:1) (1.0055 g,
61% yield). The pure exo adduct was recrystallized out as white solid from a mixture of
anisole/hexane at -20oC overnight. M.P. 189-192oC; 1H NMR (CDCl3, 400 MHz) δ7.527.14(m, 15H), 5.11(m, 1H), 5.04(s, 1H), 4.52(d, 1H, J=10.4 Hz), 4.35(dd, 1H, J=10.4, 9.0
Hz), 4.21(m, 1H), 3.75(m, 2H), 3.10(m, 1H), 1.42(d, 3H, J=6.1 Hz);

13

C NMR (CDCl3,

100 MHz) δ170.1, 152.8, 140.8, 140.0, 137.9, 129.2, 128.8, 128.6, 128.0, 127.7, 127.6,
127.4, 127.2, 126.9, 74.2, 72.5, 69.8, 61.9, 59.9, 42.3, 17.9. HR-MS(ESI/APCI) calcd
for: C27H27N2O4 (MH+): 443.1965, found: 443.1958

Preparation of 3-(2-benzhydryl-5-methyl-3-phenylisoxazolidine-4carbonyl)oxazolidin-2-one (endo adduct) (75)
To a 50 ml flame-dried flask equipped with a magnetic stir bar and

Ph

a reflux condenser fitted with a rubber septum and a balloon of Ph
nitrogen were added

N-benzylidene-benzhydrylamine N-oxide

N

O

Ph
O

(0.3182 g, 1.1 mmol), (E)-3-but-2-enoyloxazolidin-2-one (0.1586
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N
O

O

g, 1.0 mmol), powered 4A molecular sieve (193 mg), Sc(OTf)3 (0.0531 g, 0.11 mmol)
and dry CH2Cl2 (8 ml). The reaction mixture was refluxed for 9 days. A mixture of 10%
methanol and 90% CH2Cl2 (10 ml) was added and the cloudy solution was then filtered
through one layer of celite (top) and one layer of silica gel (bottom), followed by CH2Cl2
(15 ml) washing those two layers. The solvent was evaporated in vacuo. The
chromatography (3:1:1 hexane/EtOAc/CH2Cl2) afforded the pure endo adduct as white
solid (0.2309 g, 70% yield). M.P. 87-90oC; 1H NMR (CDCl3, 400 MHz) δ7.50-7.08(m,
15H), 5.36(s, 1H), 4.68(dd, 1H, J=6.7, 6.0 Hz), 4.59(d, 1H, J=6.0 Hz), 4.50(m, 1H),
4.28(m, 2H), 3.98(m, 2H), 1.49(d, 3H, J=6.1 Hz); 13C NMR (CDCl3, 100 MHz) δ172.5,
152.8, 141.5, 141.3, 141.2, 128.5, 128.3, 128.2, 128.1, 127.4, 127.2, 127.1, 127.0, 78.8,
72.4, 71.9, 61.9, 61.8, 43.0, 19.0. HR-MS(ESI/APCI) calcd for: C27H27N2O4 (MH+):
443.1965, found: 443.1952

Preparation of 3-(2-benzhydryl-3-phenylisoxazolidine-4-carbonyl)oxazolidin-2-one
Following the procedure descrided above, a mixture of exo and endo cycloadducts were
obtained from the 1, 3-dipolar cycloaddition between 3-acryloyloxazolidin-2-one and Nbenzylidene-benzhydrylamine N-oxide in the presence of either TiCl2(i-OPr)2 or
Sc(OTf)3. When TiCl2(i-OPr)2 was the catalyst, radial chromatography (5:1:1
hexane/EtOAc/CH2Cl2) gave a mixture of exo and endo cycloadducts in a ratio of 74 to
26 (43% yield). When Sc(OTf)3 was utilized, radial chromatography (5:1:1
hexane/EtOAc/CH2Cl2) afforded a mixture of exo and endo cycloadducts in a ratio of 50
to 50 (72% yield).

119

Endo adduct (77):

although radial chromatography (1:1

Et2O/petroleum ether) cannot separate exo and endo adducts

Ph
Ph

N

O

Ph

completely, pure endo adduct (eluated after exo adduct) was able

O

N

O

O

to obtain as white solid for characterization. M.P. 96-98oC; 1H

NMR (CDCl3, 400 MHz) δ7.48-7.10(m, 15H), 5.13(s, 1H), 4.68(d, 1H, J=5.6 Hz), 4.61(t,
1H, J=8.8 Hz), 4.50-4.36(m, 3H), 4.06-4.01(m, 3H);

13

C NMR (CDCl3, 100 MHz)

δ171.6, 153.1, 141.2, 140.8, 128.6, 128.4, 128.3, 128.1, 128.0, 127.9, 127.8, 127.3, 127.2,
127.1, 72.1, 69.4, 68.3, 62.2, 61.9, 57.9, 42.8. HR-MS(ESI/APCI) calcd for: C26H25N2O4
(MH+): 429.1809, found: 429.1803

Exo adduct (76): Exo adduct (92%) with minor endo adduct (8%)
was recrystallized from a solvent mixture of anisole/Hexane for
characterization. 1H NMR (CDCl3, 400 MHz) δ7.41-7.11(m,
15H), 4.99(s, 1H), 4.89(m, 1H), 4.74(t, 1H, J=8.4 Hz), 4.49(d, 1H,

Ph
Ph

N

O

Ph
O

N

O

O

J=10.0 Hz), 4.21(dd, 1H, J=8.4, 8.4 Hz), 4.12(m, 1H), 3.70(m, 2H), 3.01(m, 1H);

13

C

NMR (CDCl3, 100 MHz) δ170.0, 152.9, 141.1, 140.3, 128.7, 128.6, 128.2, 128.0, 127.9,
127.6, 127.3, 127.1, 72.2, 68.9, 66.5, 62.0, 53.0, 42.4. HR-MS(ESI/APCI) calcd for:
C26H25N2O4 (MH+): 429.1809, found: 429.1811
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Preparation of (2-benzhydryl-4-(2-oxooxazolidine-3-carbonyl)-3-phenylisoxazolidin5-yl)methyl acetate
This 1, 3 dipolar cycloaddition was conducted between N-benzylidene-benzhydrylamine
N-oxide (0.1301 g, 0.45 mmol) and (E)-4-oxo-4-(2-oxooxazolidin-3-yl)but-2-enyl acetate
(0.0880 g, 0.41 mmol) in refluxing dry CH2Cl2 (8 ml) in the presence of TiCl2(i-OPr)2
(2M in CH2Cl2, 0.04 ml) and powered 4A molecular sieve (120.1 mg) under N2
atmosphere for 9 days. The purification was realized from two times chromatography
(3:1:1 hexane/EtOAc/CH2Cl2 and 1:1 Petroleum ether/ethyl ether) to afford the pure exo
and endo adducts.
Exo adduct (79): white solid; 26% yield (0.0536 g); M. P. 83-86oC
1

; H NMR (CDCl3, 400 MHz) δ7.21-7.02(m, 15H), 5.03(m, 1H),

Ph
Ph

N
Ph

4.83(s, 1H), 4.53(dd, 1H, J=10.0, 8.0 Hz), 4.34(broad, 1H), 4.23-

O

N

O

O

4.14(m, 2H), 4.02(m, 1H), 3.61(m, 2H), 2.99(m, 1H), 1.93(s, 3H);
13

OAc

O

C NMR (CDCl3, 100 MHz) δ171.6, 170.8, 152.8, 141.1, 139.2, 136.7, 129.5, 128.9,

128.2, 128.0, 127.9, 127.8, 127.4, 126.9, 75.7, 71.8, 68.9, 63.9, 62.2, 54.4, 43.0, 20.8.
HR-MS(ESI/APCI) calcd for: C29H29N2O6 (MH+): 501.2020, found: 501.2026

Endo adduct (80): white solid; 12% yield (0.0254 g); M. P. 68o

1

71 C ; H NMR (CDCl3, 400 MHz) δ7.37-7.00(m,15H), 5.16(s,
1H), 4.64-4.56(m, 2H), 4.46(m, 2H), 4.34-4.22(m, 3H), 3.953.89(m, 2H), 1.94(s, 3H);

13

C NMR (CDCl3, 100 MHz) δ171.6,

Ph
Ph

N

OAc

O

Ph
O

N

O

O

170.8, 152.9, 140.9, 140.3, 139.5, 128.9, 128.5, 128.4, 128.1, 128.0, 127.7, 127.6, 127.2,
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127.1, 79.5, 71.8, 71.1, 63.9, 61.9, 57.6, 43.0, 20.7. HR-MS(ESI/APCI) calcd for:
C29H29N2O6 (MH+): 501.2020, found: 501.2024

Preparation of (4S)-3-(2-benzhydryl-5-methyl-3-phenylisoxazolidine-4-carbonyl)-4isopropyloxazolidin-2-one (exo adduct) (88)
Ph

This 1, 3 dipolar cycloaddition was conducted between Nbenzylidene-benzhydrylamine N-oxide (0.2834 g, 0.99 mmol) and
(S,E)-3-but-2-enoyl-4-isopropyloxazolidin-2-one (0.2356 g, 1.20

Ph

N

O
O

Ph
O

N

O

mmol) in refluxing dry CH2Cl2 (5 ml) in the presence of TiCl2(iOPr)2 (2M in CH2Cl2, 0.12 ml) and powered 4A molecular sieve (215.6 mg) under N2
atmosphere for 9 days. The chromatography (5:1 hexane/EtOAc) afforded the pure exo
adduct as white solid (0.2770 g, 58% yield). M.P. 82-85oC; 1H NMR (CDCl3, 400 MHz)
δ7.37-7.01(m, 15H), 4.97(m, 1H), 4.86(s, 1H), 4.56(d, 1H, J=10.8 Hz), 4.16-3.90(m, 4H),
1.53(m, 1H), 1.27(d, 3H, J=6.0 Hz ), 0.61(d, 3H, J=6.8 Hz), -0.01(d, 3H, J=6.8 Hz);

13

C

NMR (CDCl3, 100 MHz) δ169.3, 153.4, 141.0, 140.3, 130.0, 129.1, 128.4, 128.0, 127.9,
127.7, 127.6, 127.1, 126.8, 75.2, 72.7, 70.3, 63.3, 59.8, 58.6, 28.3, 18.1, 13.9. HRMS(ESI/APCI) calcd for: C30H33N2O4 (MH+): 485.2435, found: 485.2444

Preparation of (4S)-3-(2-benzhydryl-5-methyl-3-phenylisoxazolidine-4-carbonyl)-4benzyloxazolidin-2-one (exo adduct) (89)
This 1, 3 dipolar cycloaddition was conducted between N-benzylidene-benzhydrylamine
N-oxide (0.2543 g, 0.89 mmol) and (S,E)-4-benzyl-3-but-2-enoyloxazolidin-2-one
(0.2636 g, 1.08 mmol) in refluxing dry CH2Cl2 (5 ml) in the presence of TiCl2(i-OPr)2
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(2M in CH2Cl2, 0.11 ml) and powered 4A molecular sieve (216.3

Ph

mg) under N2 atmosphere for 11 days. The chromatography (5:1 Ph
hexane/EtOAc) afforded the pure exo adduct as white solid

N

O
O

Ph
O

(0.1922 g, 41% yield). M.P. 183-186oC; 1H NMR (CDCl3, 400

O

N

Ph

MHz) δ7.35-6.90(m, 20H), 4.95(m, 1H), 4.90(s, 1H), 4.51(d, 1H,

J=10.8 Hz), 4.22(m, 1H), 4.04(dd, 1H, J=10.8, 9.2 Hz), 3.87(t, 1H, J=8.8 Hz), 3.72(dd,
1H, J=8.8 ,2.8 Hz), 2.24(dd, 1H, J=13.6, 3.2 Hz), 1.24(d, 3H, J=6.0 Hz), 1.10(dd, 1H,
J=13.6, 11.6 Hz);

13

C NMR (CDCl3, 100 MHz) δ169.4, 152.8, 140.7, 140.6, 135.8,

129.4, 129.0, 128.9, 128.8, 128.7, 128.0, 127.9, 127.7, 127.4, 127.1, 127.0, 74.7, 73.3,
70.1, 66.2, 60.2, 54.8, 36.1, 17.8. HR-MS(ESI/APCI) calcd for: C34H33N2O4 (MH+):
533.2435, found: 533.2453

trans-5-methyl-3-phenyl-4,5-dihydroisoxazole-4-carbonyl)oxazolidin-2-one (81)
3-(2-benzhydryl-5-methyl-3-phenylisoxazolidine-4carbonyl)oxazolidin-2-one (exo adduct) (0.0542 g, 0.12 mmol) was
stirred with N-bromosuccinimide (0.0272 g, 0.15 mmol) in a mixuture

N

O

Ph
O

N

O

O

of CH2Cl2/H2O (2 ml/0.2 ml) at room temperature for 24 hours. The reaction solution was
quenched by aqueous NaHSO3 and extracted with CH2Cl2 (3x10 ml). The combined
organic layers were dried by NaSO4 and concentrated in vacuo. The resulting residue was
stirred with p-TsOH.H2O (0.0272 g, 0.14 mmol) in CH3CN/H2O (1.5 ml/1.5 ml)
overnight. The reaction solution was quenched by with Et3N. After the evaporation of
CH3CN in vacuo, followed by the addition of H2O (10 ml), the solution was extracted by
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CH2Cl2 (3x10 ml). The combined organic layers were dried by NaSO4 and concentrated
under reduced pressure. The residue was purified by radial chromatography on silica gel
(hexane/EtOAc 1:1) to provide the product (0.0159 g, 47% yield) along with a small
amount of the cis isomer as a result of epimerization at position 4 of the isoxazole. 1H
NMR (CDCl3, 400 MHz) δ 7.50(m, 2H), 7.31(m, 3H), 5.33(d, 1H, J=4.0 Hz), 4.84(m,
1H), 4.42(m, 2H), 3.96(m, 2H), 1.44(d, 3H, J=6.0 Hz); 13C NMR (CDCl3, 100 MHz) δ
169.1, 154.4, 153.7, 130.2, 128.9, 126.8, 83.0, 62.4, 53.1, 42.7, 20.8. HR-MS
(ESI/APCI) calcd for: C14H15N2O4 (MH+): 275.1026, found: 275.1025

General procedure for deprotection
A 100 ml flask was charged with diphenylmethine protected isoxazolidine, dry
CH2Cl2/TFA (4:1) and tiethylsilane (2.5 eq). The flask was flushed by N2 flow and
equipped with a reflux condenser fitted with a rubber septum and a balloon. The reaction
mixture was refluxed for 2.5 hours and was cooled to room temperature. The flask was
then placed into an ice bath and was dropwise added saturated NaHCO3 solution until the
pH became basic. The solution was extracted by CH2Cl2 (3x30 ml) and the combined
organic layers were dried by Na2SO4, filtered and concentrated under reduced pressure.
The chromatography purification (2:1 Hexane/EtOAc then 1:1 Hexane/EtOAc) provided
the N-unsubstituted isoxazolidine.
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3-(5-methyl-3-phenylisoxazolidine-4-carbonyl)oxazolidin-2-one
(deprotected

exo

adduct)

(82):

HN

O

3-(2-benzhydryl-5-methyl-3- Ph

phenylisoxazolidine-4-carbonyl)oxazolidin-2-one

(exo

O

adduct)

N

O

O

(0.0807 g, 0.18 mmol) was stirred with triethylsilane(0.0610 g, 0.53 mmol) and TFA (2
ml) in reflux CH2Cl2 (8 ml) for 2.5 hours; White solid; 93% yield (0.0467 g); M. P. 106109oC; 1H NMR (CDCl3, 400 MHz) δ7.28-7.23(m, 2H), 7.21-7.17(m, 3H), 4.91(d, 1H,
J=9.6 Hz), 4.74(m, 1H), 4.43(dd, 1H, J=9.6, 7.2 Hz), 4.09(m, 1H), 3.67(m, 2H), 3.09(m,
1H), 1.37(d, 3H, J=6.0 Hz);

13

C NMR (CDCl3, 100 MHz) δ171.2, 152.9, 134.9(small),

128.5, 128.4, 127.6, 81.6(small), 68.2, 61.9, 59.5, 42.3, 18.5. HR-MS(ESI/APCI) calcd
for: C14H17N2O4 (MH+): 277.1183, found: 277.1174

3-(5-methyl-3-phenylisoxazolidine-4-carbonyl)oxazolidin-2-one (deprotected endo
adduct)

(83):

3-(2-benzhydryl-5-methyl-3-phenylisoxazolidine-4-

carbonyl)oxazolidin-2-one (endo adduct) (0.1146 g, 0.26 mmol) was

HN

O

stirred with triethylsilane(0.0810 g, 0.70 mmol) and TFA (2 ml) in Ph
reflux CH2Cl2 (8 ml) for 2.5 hours; White solid; 83% yield (0.0593

N
O

O

O

g); M. P. 131-134oC ; 1H NMR (CDCl3, 400 MHz) δ7.39(d, 1H, J=7.2 Hz), 7.27(m, 2H),
7.20(m, 1H), 4.76(d, 1H, J=3.6 Hz), 4.68(dd, 1H, J=5.2, 3.6 Hz), 4.37(m, 2H), 4.27(m,
1H), 4.02(m, 2H), 1.29(d, 3H, J=6.0 Hz);

13

C NMR (CDCl3, 100 MHz) δ173.7, 153.1,

139.3, 128.7, 127.7, 127.0, 84.4, 69.1, 62.0, 59.7, 43.0, 19.2. HR-MS(ESI/APCI) calcd
for: C14H17N2O4 (MH+): 277.1183, found: 277.1181
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3-(3-phenylisoxazolidine-4-carbonyl)oxazolidin-2-one (deprotected endo adduct)
(85): 3-(2-benzhydryl-3-phenylisoxazolidine-4-carbonyl)oxazolidin-

HN

O

2-one (endo adduct) (0.0556 g, 0.13 mmol) was stirred with Ph
O

triethylsilane(0.0456 g, 0.39 mmol) and TFA (1.5 ml) in reflux

N

O

O
o

CH2Cl2 (6 ml) for 2.5 hours; White solid; 87% yield (0.0295 g); M. P. 144-146 C ; 1H
NMR (CDCl3, 400 MHz) δ7.39-7.18(m, 5H), 4.87(d, 1H, J=4.0 Hz), 4.60(m, 1H), 4.404.28(m, 3H), 4.02-3.93(m, 3H);

13

C NMR (CDCl3, 100 MHz) δ172.8(small), 153.3,

128.8, 127.9, 127.5, 127.0, 74.0, 66.4, 62.3, 55.3, 42.7. HR-MS(ESI/APCI) calcd for:
C13H15N2O4 (MH+): 263.1026, found: 263.1034

3-(3-phenylisoxazolidine-4-carbonyl)oxazolidin-2-one (deprotected exo adduct) (84):
3-(2-benzhydryl-3-phenylisoxazolidine-4-carbonyl)oxazolidin-2-one
(92% exo adduct and 8% endo adduct) (0.0603 g, 0.14 mmol) was

HN

O

stirred with triethylsilane(0.0467 g, 0.40 mmol) and TFA (1.5 ml) in Ph
O

reflux CH2Cl2 (6 ml) for 2.5 hours to give predominant deprotected

N

O

O

exo adduct with small amount of deprotected endo adduct (0.0372 g, quantative yield).
Deprotected exo adduct: 1H NMR (CDCl3, 400 MHz) δ7.25-7.16(m, 5H), 5.00(m, 1H),
4.79(d, 1H, J=8.8 Hz), 4.50(m, 1H), 4.13-4.06(m, 2H), 3.76-3.61(m, 2H), 3.05(m, 1H);
13

C NMR (CDCl3, 100 MHz) δ171.1(small), 153.0, 128.7, 128.4, 128.2, 127.5, 72.9,

67.6, 62.0, 55.2, 42.4. HR-MS(ESI/APCI) calcd for: C13H15N2O4 (MH+): 263.1026,
found: 263.1036
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(4S)-4-isopropyl-3-(5-methyl-3-phenylisoxazolidine-4carbonyl)oxazolidin-2-one (deprotected exo adduct) (91): (4S)-3-

HN

O
O

Ph

(2-benzhydryl-5-methyl-3-phenylisoxazolidine-4-carbonyl)-4-

O

N

O

isopropyloxazolidin-2-one (exo adduct) (0.0896 g, 0.19 mmol) was
stirred with triethylsilane(0.0596 g, 0.51 mmol) and TFA (2 ml) in reflux CH2Cl2 (8 ml)
for 3 hours; White solid; 81% yield (0.0479 g); M. P. 120-123oC; 1H NMR (CDCl3, 400
MHz) δ7.25(m, 5H), 5.00(d, 1H, J=9.6 Hz), 4.70(m, 1H), 4.32(dd, 1H, J=9.6, 8.0 Hz),
4.19(m, 1H), 4.12(dd, 1H, J=8.8, 8.4 Hz), 4.01(dd, 1H, J=8.8, 2.4 Hz), 1.59(m, 1H),
1.39(d, 3H, J=6.0 Hz), 0.64(d, 3H, J=6.8 Hz), 0.00(d, 3H, J=6.8 Hz); 13C NMR (CDCl3,
100 MHz) δ171.0, 153.5, 135.0, 128.7, 128.6, 128.5 128.3, 83.0, 68.5, 63.2, 59.0, 58.7,
28.3, 18.6, 18.0, 13.7. HR-MS(ESI/APCI) calcd for: C17H23N2O4 (MH+): 319.1652,
found: 319.1662
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